415.
|
Mroczkowski P., Kim S., Otto R., Lippert H., Zajdel R., Zajdel K., Merecz-Sadowska A.
Prognostic
Value of Metastatic Lymph Node Ratio and Identification of Factors
Influencing the Lymph Node Yield in Patients Undergoing Curative Colon
Cancer Resection.
Cancers (Basel), 16 (1), (2024).
https://doi.org/10.3390/cancers16010218
|
414.
|
Stumpf J., Budde K., Witzke O., Sommerer C., Vogel T., Schenker P.,
Woitas R.P., Opgenoorth M., Trips E., Schrezenmeier E., Hugo C., German
S & L Study.
Fixed low dose versus concentration-controlled
initial tacrolimus dosing with reduced target levels in the course after
kidney transplantation: results from a prospective randomized
controlled non-inferiority trial (Slow & Low study).
EClinicalMedicine 67 (2024).
https://doi.org/10.1016/j.eclinm.2023.102381 |
413.
|
Assfalg V., Miller G., Stocker F., Hüser N., Hartmann D., Heemann U.,
Tieken I., Zanen W., Vogelaar S., Rosenkranz A.R., Schneeberger S.,
Függer R., Berlakovich G., Ysebaert D.R., Jacobs-Tulleneers-Thevissen D.,
Mikhalski D., van Laecke S., Kuypers D., Mühlfeld A.S., Viebahn R.,
Pratschke J., Melchior S., Hauser I.A., Jänigen B., Weimer R., Richter
N., Foller S., Schulte K., Kurschat C., Harth A., Moench C., Rademacher
S., Nitschke M., Krämer B.K., Renders L., Koliogiannis D., Pascher A.,
Hoyer J., Weinmann-Menke J., Schiffer M., Banas B., Hakenberg O.,
Schwenger V., Nadalin S., Lopau K., Piros L., Nemes B., Szakaly P.,
Bouts A., Bemelman F.J., Sanders J.S., de Vries A.P.J., Christiaans M.H.L.,
Hilbrands L., van Zuilen A.D., Arnol M., Stippel D., Wahba R.
Rescue
Allocation Modes in Eurotransplant Kidney Transplantation: Recipient
Oriented Extended Allocation Versus Competitive Rescue Allocation-A
Retrospective Multicenter Outcome Analysis.
Transplantation 2023 Dec 11 (2023).
https://doi.org/10.1097/tp.0000000000004878 |
412.
|
Blazquez-Navarro
A., Roch T., Wehler P., Stervbo U., Bauer
C., Wolk K., Sabat R., Dang-Heine C., Thomusch
O., Reinke P., Hugo C., Zgoura P., Viebahn
R., Westhoff T., Or-Guil M., Babel N.
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivation.
Journal of Nephrology 36, 1071-1073 (2023).
https://doi.org/10.1007/s40620-022-01487-7 |
411
|
Brom V.C., Strauss A.C., Sieberath A., Salber J., Burger C., Wirtz DC., Schildberg F.A.
Agonistic and antagonistic targeting of immune checkpoint molecules differentially regulate osteoclastogenesis.
Frontiers in Immunology 14 (2023).
https://doi.org/10.3389/fimmu.2023.988365
|
410.
|
Cameron D.P., Grosser J., Ladigan S., Kuzin V., Iliopoulou E., Wiegard
A., Benredjem H., Jackson K., Liffers S.T., Lueong S., Cheung P.F.,
Vangala D., Pohl M., Viebahn R., Teschendorf C., Wolters H., Usta S.,
Geng K., Kutter C., Arsenian-Henriksson M., Siveke J.T., Tannapfel A.,
Schmiegel W., Hahn S.A. Baranello L.
Coinhibition of topoisomerase 1
and BRD4-mediated pause release selectively kills pancreatic cancer via
readthrough transcription.
Science Advances 9 (41) (2023).
https://doi.org/10.1126/sciadv.adg5109 |
409.
|
Channane H., Shaporov A., Sandica A., Atay S., Snopok I., Frunza T., Viebahn R.
Popliteal endarterectomy at the leg level with venous enlargement patch: about 14 cases.
Journal of Surgical Case Reports 2023 (7), jrad398 (2023).
https://doi.org/10.1093/jscr/rjad398 |
408.
|
Channane H., Spiliotis P.M., Sandica A.M., Snopok I., Viebahn R.
A rare cause of unilateral leg swelling: May-Thurner Syndrome.
Journal of Surgical Case Reports 2023 (5), rjad232 (2023).
https://doi.org/10.1093/jscr/rjad232 |
407.
|
De Fijter J., Dreyer G., Mallat M., Budde K., Pratschke J., Klempnauer
J., Zeier M., Arns W., Hugo C., Rump L.C., Hauser I., Schenker P.,
Schiffer M., Grimm M.O., Kliem V., Olbricht C.J., Pisarski P., Banas B.,
Suwelack B., Hakenberg O., Berlakovich G., Schneeberger S., van de
Wetering J., Berger S., Bemelman F., Kuypers D., Heidt S., Rahmel A.,
Claas F., Peeters P., Oberbauer R., Heemann U., Krämer B.K.,
Eurotransplant Senior DR-compatible Program (ESDP) Study Group.
A
paired-kidney allocation study found superior survival with HLA-DR
compatible kidney transplants in the Eurotransplant Senior Program.
Kidney International 104 (3), 552-561 (2023).
https://doi.org/10.1016/j.kint.2023.05.025 |
406.
|
Linke P., Wilhelm P., Levent A., Gehrke T., Salber J., Akkaya M., Suero E.M., Citak M.
Anatomical risk factors for aseptic loosening of full hinge knee prosthesis in primary and revision TKAs.
Archives of Orthopaedic and Trauma Surgery (2023).
https://doi.org/10.1007/s00402-023-04776-3
|
405.
|
Piakong P., Pahl M., Delgado G., Akkaya M., Busch S.M., Salber J., Gehrke T., Citak M.
Twenty-Year Results of a Neck-Preserving Short-Stem Prosthesis in Primary Total Hip Arthroplasty.
Archives of Orthopaedic and Trauma Surgery (2023).
https://doi.org/10.1007/s00402-022-04556-5 |
404.
|
Mroczkowski P.
Comment
on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for
Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia
(CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two
Overtreatments Compared.
Annals of Surgery Open 4 (2), e295 )(2023).
https://doi.org/10.1097/as9.0000000000000295
|
403.
|
Mroczkowski P., Dziki L., Vosikova T., Otto R., Merecz-Sadowska A.
Rectal Cancer: Are 12 Lymph Nodes the Limit?
Cancers (Basel) 15 (13), 3447 (2023).
https://doi.org/10.3390/cancers15133447
|
402.
|
Reissig T.M., Ladigan-Badura S., Steinberg A., Maghnouj A., Li T.,
Verdoodt B., Liffers S.T., Pohl M., Wolters H., Teschendorf C., Viebahn
R., Admard J., Casadei N., Tannapfel A., Schmiegel W., Hahn S.A., Vangala
D.B.
Lasting response by vertical inhibition with cetuximab
and trametinib in KRAS-mutated colorectal cancer patient-derived
xenografts.
Molecular Oncology 17 (11), 2396-2414 (2023).
https://doi.org/10.1002/1878-0261.13510 |
401.
|
Sandica A., Baraksei D,. Hüsken S., Viebahn R., Snopok I.
Pneumoperitoneum: always a surgical case?
Journal of Surgical Case Reports 2023 (5), rjad250 (2023).
https://doi.org/10.1093/jscr/rjad250 |
400.
|
Scholz T., Akkaya M., Linke P., Busch S.M., Gehrke T., Salber J., Citak M.
The
anatomical shape of the distal femur is an independent risk factor for
aseptic loosening following one-stage septic knee revision using
rotating hinge knee prosthesis.
Archives of Orthopaedic and Trauma Surgery, 143 (1), 481-488 (2023).
https://doi.org/10.1007/s00402-021-04327-8 |
399.
|
Stumpf J., Budde K., Witzke O., Sommerer C., Thomas V., Schenker P.,
Woitas R., Opgenoorth M., Trips E., Schrezenmeier E., Hugo C.
Fixed
low dose versus concentration-controlled initial tacrolimus dosing with
reduced target levels in the course after kidney transplantation:
results from a prospective randomized controlled non-inferiority trial
(Slow & Low study).
Nephrology Dialysis Transplantation 38 Suppl 1, I934-I935 (2023).
https://doi.org/10.1093/ndt/gfad063c_4233
|
398.
|
Van den Eeden Y.N.T., Zeiton M., Akkaya M., Salber J., Gehrke T., Citak M.
The anatomical shape of the proximal femur correlates with the distal femur anatomy.
Archives of Orthopaedic and Trauma Surgery 143 (8), 5221-5227 (2023).
https://link.springer.com/article/10.1007/s00402-023-04833-x |
397.
|
Akkaya M., Vles G., Bakhtiari I.G., Sandiford A., Salber J., Gehrke T., Citak M.
What is the rate of reinfection with different and difficult-to-treat bacteria after failed one-stage septic knee exchange?
International Orthopaedics 46, 687–695 (2022).
https://doi.org/10.1007/s00264-021-05291-z |
396.
|
Bakhtiari I.G., Vles G., Busch S.M., Frommelt L., Gehrke T., Salber J., Citak M.
Septic failure after one-stage exchange for prosthetic joint infection of the hip: microbiological implications.
Journal of Arthroplasty 37 (2), 373-378 (2022).
https://doi.org/10.1016/j.arth.2021.10.020
|
395.
|
Gehrke
T., Althaus L., Linke P., Salber J., Krenn V., Citak M.
Arthrofibrosis
following primary total hip arthroplasty: a distinct clinical entity.
Archives of
Orthopaedic and Trauma Surgery 142, 511–515 (2022).
https://doi.org/10.1007/s00402-021-03922-z |
394.
|
Gruhn D., Viebahn R., Salber J.
Dynamic
In Vitro Long-Term cultivation of a Multi-Cellular Tubular Bone Model
to Investigate the Biocompatibility of New Bone Implants.
Tissue Engeneering Part A 28, S281 (2022).
|
393.
|
Heid I., Münch C., Karakaya
S., Lueong S.S., Winkelkotte A.M., Liffers S.T., Godfrey L., Cheung P.F.Y., Savvatakis
K., Topping G.J., Englert F., Kritzner L., Grashei M., Tannapfel A., Viebahn R.,
Wolters H., Uhl W., Vangala D., Smeets E.M.M., Aarntzen E.H.J.G., Rauh D., Weichert
W., Hoheisel J.D., Hahn S.A., Schilling F., Braren R., Trajkovic-Arsic M., Siveke
J.T.
Functional noninvasive detection of glycolytic pancreatic ductal
adenocarcinoma.
Cancer & Metabolism 10, Article number: 24 (2022).
https://doi.org/10.1186/s40170-022-00298-5
|
392.
|
Jahn N., Sack U., Stehr S., Vöelker M.T., Laudi S., Seehofer D., Atay S., Zgoura P., Viebahn R., Boldt A., Hau H.M.
The Role of Innate Immune Cells in the Prediction of Early Renal Allograft Injury Following Kidney Transplantation.
Jounal of Clinical Medicine 11 (20), 6148 (2022).
https://doi.org/10.3390/jcm11206148
|
391.
|
Karimzadeh L., Salber J., Seyedjafari E., Hosein G., Nabiuni M., Majlesara M.
Assessment
of the Bone Regeneration Potential of Spin-Coated Zinc
Silicate/Polycaprolactone Composites in a Wistar Rat Femoral
Osteonecrosis Bone Model.
Tissue Engeneering Part A 28 (S1), S609 (2022).
|
390.
|
Mroczkowski P.
Do Danish Registry data document superiority of open surgery for colon cancer?
Colorectal Disease 24 (9), 1087 (2022)
https://doi.org/10.1111/codi.16141
|
389.
|
Mroczkowski P., Zajdel R.
Is Neoadjuvant Chemoradiotherapy Beneficial for Patients With Pancreatic Cancer?
Journal of Clinical Oncology 40 (28), 3347-3348 (2022).
https://doi.org/10.1200/JCO.22.00454
|
388.
|
Roch
T., Rohn B., Blazquez-Navarro A., Meister T.L., Blanco E.V., Paniskaki
K., Wellenkötter J., Zgoura P., Giglio T., Pfaender S., Stervbo U.,
Viebahn R., Cinkilic O., Westhoff T.H., Babel N.
A
Vector-Based Vaccine Dose After 3 Doses of mRNA-Based COVID-19
Vaccination Does Not Substantially Improve Humoral SARS-CoV-2 Immunity
in Renal Transplant Recipients.
Kidney International Reports 7 (4), 932-934 (2022).
https://doi.org/10.1016/j.ekir.2022.01.1068
|
387.
|
Salber J., Shah S.
In Vivo Simulative Biocompatibility Assessment of Bioresorbable Cardiovascular Scaffolds.
Tissue Engeneering Part A 28 (S1), S457 (2022).
|
386.
|
Snopok I., Viebahn R., Walz M., Zgoura P., Alesina P.F.
Minimally
invasive video-assisted parathyroidectomy (MIVAP) versus conventional
parathyroidectomy for renal hyperparathyroidism: a retrospective
multicenter study.
Updates in Surgery 74 (4), 1419-1428 (2022).
https://doi.org/10.1007/s13304-022-01291-9
|
385.
|
Thieme
C.J., Schulz M., Wehler P., Anft M., Amini L., Blàzquez-Navarro A.,
Stervbo U., Hecht J., Nienen M., Stittrich A.B., Choi M., Zgoura P.,
Viebahn R., Schmueck-Henneresse M., Reinke P., Westhoff T.H., Roch T.,
Babel N.
In
Vitro and In Vivo Evidence That the Switch From Calcineurin to Mtor
Inhibitors May Be a Strategy For Immunosuppression in Epstein-Barr
Virus-Associated Post-Transplant Lymphoproliferative Disorder.
Kidney International 102 (6), 1392-1408 (2022).
https://doi.org/10.1016/j.kint.2022.08.025
|
384.
|
Zgoura P., Doevelaar A., Rohn B., Seibert F.S., Seidel M., Heinemann F.M., Pillokeit N., Viebahn R., Babel N., Westhoff T.H.
Effect
of Nephrectomy After Allograft Failure on Inflammation, Erythropoiesis,
Donor-Specific Antibodies, and Outcome of Re-Transplantation.
Annals of Transplantation 27 , e935625 (2022).
https://doi.org/10.12659/AOT.935625
|
383.
|
Abdelaziz H., Schröder M., Shum Tien C., Ibrahim K., Gehrke T., Salber J., Citak M.
Resection of the proximal femur during one-stage revision for infected hip arthroplasty : risk factors and effectiveness.
Bone & Joint Journal 103-B (11), 1678-1685 (2021).
https://doi.org/10.1302/0301-620X.103B11.BJJ-2021-0022.R1 |
382.
|
Anft
M., Blazquez-Navarro A., Stervbo U., Skrzypczyk S., Witzke O., Wirth
R., Choi M., Hugo C., Reinke P., Meister T.L., Steinmann E., Pfaender
S., Schenker P., Viebahn R., Westhoff T.H., Babel N.
Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients.
Journal of Nephrology 34 (4), 1025-1037 (2021).
https://doi.org/10.1007/s40620-021-01092-0
|
381.
|
Bardeei L.K., Seyedjafari E., Hossein G., Nabiuni M., Ara M.H.M., Salber J.
Regeneration
of bone defects in a rabbit femoral osteonecrosis model using
3D-printed poly (epsilon-caprolactone)/nanoparticulate willemite
composite scaffolds.
International Journal of Molecular Sciences 22 (19) (2021).
https://doi.org/10.3390/ijms221910332
|
380.
|
Boggi
U., Vistoli F., Andres A., Arbogast H.P., Badet L., Baronti W.,
Bartlett S.T., Benedetti E., Branchereau J., Burke G.W., Buron F.,
Caldara R., Cardillo M., Casanova D., Cipriani F., Cooper M., Cupisti
A., Davide J., Drachenberg C., Koning E.J.P., Ettorre G.M., Cruz L.F.,
Fridell J.A., Friend P.J., Furian L., Gaber O.A., Gruessner A.C.,
Gruessner R.W.G., Gunton J.E., Han D.J., Iacopi S., Kauffmann E.F.,
Kaufman D., Kenmochi T., Khambalia H.A., Lai Q., Langer R.M., Maffi P.,
Marselli L., Menichetti F., Miccoli M., Mittal S., Morelon E., Napoli
N., Neri F., Oberholzer J., Odorico J.S., Ollinger R., Oniscu G.,
Orlando G., Ortenzi M., Perosa M., Perrone V.G., Pleass H., Redfield
R.R., Ricci C., Rigotti P., Robertson R., Ross L.F., Rossi M., Saudek
F., Scalea J.R., Schenker P., Secchi A., Socci C., Silva D.S.,
Squifflet J.P., Stock P.G., Stratta R.J., Terrenzio C., Uva P., Watson
C.C.E., White S.A., Marchetti P., Kandaswamy R., Berney T.
First World Consensus Conference on Pancreas Transplantation: Part II - Recommendations.
American Journal of Transplantation 21 (S3), 17-59 (2021).
https://doi.org/10.1111/ajt.16750
|
379.
|
Buettner-Herold M., Amann K., Pfister F., Tannapfel A., Maslova M., Wunsch A., Pillokeit N., Viebahn R., Schenker P.
Pancreas transplantation-clinic, technique, and histological assessment.
Pathologe 42 (S5), 509-523 (2021)
https://doi.org/10.1007/s00292-021-00982-1
|
378.
|
Ciardelli G., Boccaccini A.R., Roy I., Nostro A., Salber J.
Editorial: Combating bacterial infections through biomimetic or bioinspired materials design and enabling technologies.
Frontiers in Bioengineering and Biotechnology 9 (2021).
https://doi.org/10.3389/fbioe.2021.818643
|
377.
|
Grzella
S., Hinzmann J., Pillokeit N., Lengenfeld T., Vaihinger H.M., Zgoura
P., Westhoff T.H., Viebahn R., Schenker P.
Impact
of Histidine-Tryptophan-Ketoglutarate Versus University of Wisconsin
Solution on the Outcome of Pancreas Transplant With Cold Ischemic Time
≥12 Hours: A Retrospective Study.
Experimental and
Clinical Transplantation 19 (8), 842-848 (2021).
https://doi.org/10.6002/ect.2020.0544
|
376.
|
Hugo
C., Weihprecht H., Banas B., Schröppel B., Jank S., Arns W., Schenker
P., Rath T., Hergesell O., Feldkamp T., Hermann B., Schiffer M.
Renal
Function and Patient-Reported Outcomes in Stable Kidney Transplant
Patients Following Conversion From Twice-Daily Immediate-Release
Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month
Observational Study in Routine Clinical Practice in Germany (ADAGIO).
Transplantation
Proceedings 53 (5), 1484-1493 (2021)
https://doi.org/10.1016/j.transproceed.2021.01.034
|
375.
|
Kamarajah
S.K., Arbogast H., Berney T., Boggi U., Branchereau J., Socci C.,
Casanova D., Cooper M., Drage M., Elker D., Ferrer J., Furian L.,
Gruessner R., Harper S., Kwiatkowski A., Kenmochi T., Manas D., Morelon
E., Odorico J., Oellinger R., Oniscu G., Perosa M., Saudek F., Scalea
J., Schenker P., Stratta R., Vistulo F., Uva P., White S.A. [World Pancreas Transplant Covid-19 Collaborative Group]
Impact of SARS-CoV-2 on pancreas transplant activity: survey of international surgeons.
British Journal of Surgery 108 (3), E109-E110 (2021).
https://doi.org/10.1093/bjs/znaa105
|
374.
|
Lehner
L.J., Kalb K., Weigand K., Pein U., Schenker P., Seeger W., Roehle R.,
Dienes K., Halleck F., Budde K.
STABIL-study:
The Course of Therapy, Safety and Pharmacokinetic Parameters of
Conversion of Prograf® to Tacrolimus HEXAL®/Crilomus® in Renal
Transplant Recipients - an Observational Study in Germany.
Current
Clinical Pharmacology 16 (4), 357-368 (2021).
https://doi.org/10.2174/1574884716666210215102756
|
373.
|
Nowak
H., Vornweg S., Rump K., Rahmel T., Unterberg M., Koos B., Schenker P.,
Viebahn R., Adamzik M., Bergmann L.
The
NFKB1 Promoter Polymorphism (-94ins/delATTG) Is Associated with
Susceptibility to Cytomegalovirus Infection after Kidney
Transplantation and Should Have Implications on CMV Prophylaxis
Regimens.
CELLS
10 (2), No.
380 (2021).
https://www.mdpi.com/2073-4409/10/2/380/htm |
372.
|
Ohlmeier
M., Alrustom F., Citak M., Salber J., Gehrke T., Frings J.
What Is the
Mid-Term Survivorship of Infected Rotating-Hinge Implants Treated with
One-stage-exchange?
Clinical
Orthopaedics and Related Research 2021 Jun 21. Online ahead of
print.
https://doi.org/10.1097/CORR.0000000000001868
|
371.
|
Pillokeit N., Grzella S., Zgoura P., Westhoff T., Viebahn R., Schenker P.
Challenges associated with pancreas and kidney retransplantation-a retrospective analysis.
Journal of Clinical Medicine 10 (16), 3634 (2021).
https://doi.org/10.3390/jcm10163634
|
370.
|
Pillokeit N., Grzella S., Westhoff T., Viebahn R., Schenker P.
High mortality rate after simultaneous pancreas kidney retransplantation.
Transplant International 34 (S2), 28 (2021).
|
369.
|
Prange F., Seifert A., Piakong P., Gehrke
T., Guttowski D., Busch S.M., Salber J., Citak M.
Correction
to: Short-term mortality after primary and revision total joint
arthroplasty: a single-center analysis of 103,560 patients.
Archives of
Orthopaedic and Trauma Surgery
141, 1433 (2021).
https://doi.org/10.1007/s00402-021-03964-3
|
368.
|
Prange F.,
Seifert A., Piakong P., Gehrke T., Guttowski D., Busch S.M., Salber J.,
Citak M.
Short-term
mortality after primary and revision total joint arthroplasty: a
single-center analysis of 103,560 patients.
Archives
of Orthopaedic and Trauma Surgery 141 (3),
517-525 (2021).
https://pubmed.ncbi.nlm.nih.gov/33388890/
|
367.
|
Rahmel T., Nowak H., Frisenda S., Rump K., Koos B., Schenker P., Viebahn R., Adamzik M., Bergmann L.
Corrigendum:
The aquaporin 5 -1364A/C promoter polymorphism is associated with
cytomegalovirus infection risk in kidney transplant recipients (vol 10,
2871, 2019).
Frontiers in Immunology 12, (2021).
https://doi.org/10.3389/fimmu.2021.739229
|
366.
|
Sinning
C., Zengin E., Diller G.P., Onorati F., Castel M.A., Petit T., Chen
Y.S., Lo Rito M., Chiarello C., Guillemain R., Nubret-Le Coniat K.,
Magnussen C., Knappe D., Becher P.M., Schrage B., Smits J.M., Metzner
A., Knosalla C., Schoenrath F., Miera O., Cho M.Y., Bernhardt A.,
Weimann J., Gossling A., Terzi A., Amodeo A., Alfieri S., Angeli E.,
Ragni L., Napoleone C.P., Gerosa G., Pradegan N., Rodrigus I., Dumfarth
J., Pauw M., Francois K., Van Caenegem O., Ancion A., Van Cleemput J.,
Milicic D., Moza A., Schenker P., Thul J., Steinmetz M., Warnecke G.,
Ius F., Freyt S., Avsar M., Sandhaus T., Haneya A., Eifert S., Saeed
D., Borger M., Welp H., Ablonczy L., Schmack B., Ruhparwar A., Naito
S., Hua X.Q., Fluschnik N., Nies M., Keil L., Senftinger J., Ismaili
D., Kany S., Csengeri D., Cardillo M., Oliveti A., Faggian G., Dorent
R., Jasseron C., Blanco A.P., Marquez J.M.S., Lopez-Vilella R.,
Garcia-Alvarez A., Lopez M.L.P., Rocafort A.G., Fernandez O.G.,
Prieto-Arevalo R., Zatarain-Nicolas E., Blanchart K., Boignard A.,
Battistella P., Guendouz S., Houyel L., Para M., Flecher E., Gay A.,
Epailly E., Dambrin C., Lam K., Ka-lai C.H., Cho Y.H., Choi J.O., Kim
J.J., Coats L., Crossland D.S., Mumford L., Hakmi S., Sivathasan C.,
Fabritz L., Schubert S., Gummert J., Hubler M., Jacksch P., Zuckermann
A., Laufer G., Baumgartner H., Giamberti A., Reichenspurner H.,
Kirchhof P.
Study design and rationale of the patients presenting with congenital heart disease register (ARTORIA-R).
ESC Heart Failure 8 (6), 5542-5550 (2021).
https://doi.org/10.1002/ehf2.13574
|
365.
|
Thieme
C.J., Zgoura P., Todorova I., Babel D., Witzke O., Viebahn R., Halleck
F., Bachmann F., Westhoff T.H., Choi M., Babel N.
Coronavirus Disease
2019 Associated Risk Score, Behavior, and Symptom Prevalence in German
Transplant Recipients.
Transplantation
Proceedings 53 (4),
1245-1248 (2021).
https://doi.org/10.1016/j.transproceed.2020.12.001
|
364.
|
Thieme
C.J., Anft M., Paniskaki K., Blazquez-Navarro A., Doevelaar A., Seibert
F.S., Hoelzer B., Konik M.J., Meister T.L., Pfaender S., Steinmann E.,
Berger M.M., Brenner T., Kölsch U., Dolff S., Roch T., Witzke O.,
Schenker P., Viebahn R., Stervbo U., Westhoff T.H., Babel N.
The
Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral
Immunity in Transplant Population Is Similar to the General Population
Despite Immunosuppression.
Transplantation 105 (10),2156-2164
(2021).
https://doi.org/10.1097/TP.0000000000003755
|
363.
|
Thieme
C., Anft M., Paniskaki K., Navarro A.B., Doevelaar A.A.N., Seibert
F.S., Hoelzer B., Konik M.J., Meister T.L., Pfander S., Steinmann E.,
Berger M.M., Brenner T., Kolsch U., Dolff S., Roch T., Witzke O.,
Schenker P., Viebahn R., Stervbo U., Westhoff T.H., Babel N.
SARS-CoV-2
reactive cellular and humoral immunity in transplant population is
similar to the general population despite immunosuppression.
Transplant International 34 (S1), 88 (2021).
|
362.
|
Vangala
D., Ladigan S., Liffers S.T., Noseir S., Maghnouj A., Gotze T.M.,
Verdoodt B., Klein-Scory S., Godfrey L., Zowada M.K., Huerta M.,
Edelstein D.L., de Villarreal J.M., Marques M., Kumbrink J., Jung A.D.,
Schiergens T., Werner J., Heinemann V., Stintzing S., Lindoerfer D.,
Mansmann U., Pohl M., Teschendorf C., Bernhardt C., Wolters H., Stern
J., Usta S., Viebahn R., Admard J., Casadei N., Frohling S., Ball C.R.,
Siveke J.T., Glimm H., Tannapfel A., Schmiegel W., Hahn S.A.
Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.
Genome Medicine 13 (1), 116 (2021).
https://doi.org/10.1186/s13073-021-00926-7
|
361.
|
Vasquez
J.M., Idrees A., Carmagnola I., Sigen A., McMahon S., Marlinghaus L.,
Ciardelli G., Greiser U., Tai H.Y., Wang W.X., Salber J., Chiono V.
In situ forming hyperbranched peg-thiolated hyaluronic acid hydrogels with honey-mimetic antibacterial properties.
Frontiers in Bioengineering and Biotechnology 9, 742135 (2021).
https://doi.org/10.3389/fbioe.2021.742135
|
360.
|
Waldecker C., Zgoura P., Gall S., Seibert F.S., Rohn B., Schenker P., Bauer F., Viebahn R., Babel N., Westhoff T.H.
Biopsy
findings after detection of de novo donor-specific antibodies in renal
transplant recipients - a single center experience.
Transplant International 34 (S1), 292 (2021).
|
359.
|
Waldecker
C.B., Zgoura P., Seibert F.S., Gall S., Schenker P., Bauer F., Rohn B.,
Viebahn R., Babel N., Westhoff T.H.
Biopsy findings
after detection of de novo donor-specific antibodies in renal
transplant recipients: a single center experience.
Journal
of Nephrology 34 (6), 2017-2026 (2021).
https://doi.org/10.1007/s40620-021-01040-y |
358.
|
Westhoff
T.H., Seibert F.S., Anft M., Blazquez-Navarro A., Skrzypczyk S., Zgoura
P., Meister T.L., Pfaender S., Stumpf J., Hugo C., Viebahn R., Roch T.,
Stervbo U., Babel N.
A
third vaccine dose substantially improves humoral and cellular
SARS-CoV-2 immunity in renal transplant recipients with primary humoral
nonresponse.
Kidney International 100 (5), 1135-1136 (2021).
https://doi.org/10.1016/j.kint.2021.09.001
|
357.
|
Zgoura P., Doevelaar A.A.N., Rohn B., Seibert F., Seidel M., Schenker P., Zwiener A., Babel N., Viebahn R., Westhoff T.
The impact of nephrectomy after allograft failure on chronic inflammatory state, DSA and outcome of re-transplantation.
Transplant International 34 (S2), 11 (2021).
|
356.
|
Abdelaziz H., Rademacher K., Suero E. M.,
Gehrke T., Lausmann C., Salber J., Citak M.
The 2018 International
Consensus Meeting
Minor Criteria for Chronic Hip and Knee Periprosthetic Joint Infection:
Validation From a Single Center.
The
Journal of Arthroplasty 35 (8),
2200-2203 (2020).
https://doi.org/10.1016/j.arth.2020.03.014
|
355.
|
Anft
M., Blazquez-Navarro A., Stervbo U., Witzke O., Wirth R., Choi M., Hugo
C., Reinke P., Schenker P., Viebahn R., Westhoff T., Babel N.
Pre-existing
SARS-CoV-2 reactive T cells in renal transplant patients.
Transplant
International 33 (S2),
11-12 (2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13732
|
354.
|
Babel
N., Anft M., Blazquez-Navarro A., Doevelaar A.A.N.,
Seibert F.S., Bauer F., Rohn B.J., Hoelzer B., Thieme C.J., Roch T.,
Meister T.L.,
Pfaender S., Steinmann E., Dittmer U., Schenker P., Amann K., Viebahn
R.,
Stervbo U., Westhoff T.H.
Immune
monitoring facilitates the clinical decision in multifocal COVID-19 of
a
pancreas-kidney transplant patient.
American Journal of Transplantation 20 (11), 3210-3215
(2020).
https://doi.org/10.1111/ajt.16252. |
353.
|
Babel
N., Anft M., Blazquez-Navarro A., Paniskaki K., Doevelaar A.A.N.,
Seibert F., Hoelzer B., Thieme C., Konik M., Brenner T., Dolff S., Roch
T., Witzke O., Stervbo U., Westhoff T., Viebahn R.
Transplant
patients are able to mount SARS-CoV-2-reactive t-cell response with the
magnitude and functionality comparable to non-immunosuppressed patients.
Transplant
International 33 (S2), 11
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13732
|
352.
|
Babel
N., Stervbo U., Seibert F., Bauer F., Anft M., Rohn B., Winnekendonk
G., Dittmer U., Schenker P., Amann K., Viebahn R., Westhoff T.
Monitoring
of general immune status and SARS-CoV-2 reactive T-cell and humoral
immunity facilitates the clinical decision in a severe
SARS-CoV-2-associated pneumonia, meningoencephalitis and
gastroenteritis in a pancreas-kidney transplant patient.
Transplant
International 33 (S2), 23
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
351.
|
Bajda
S., Blazquez-Navarro A., Samans B., Wehler P., Kaliszczyk S., Amini L.,
Schmueck-Henneresse M., Witzke O., Dittmer U., Westhoff T.H., Viebahn
R., Reinke P., Thomusch O., Hugo C., Olek S., Roch T., Babel N.
The role of soluble
mediators in the clinical course of EBV infection and B cell
homeostasis after kidney transplantation.
Scientific
Reports 10
(1), No. 19594 (2020).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658229/
|
350.
|
Becher
P.M., Schrage B., Weimann J., Smits J., Magnussen C., Reichenspurner
H., Goßling A., Rodrigus I., Dumfarth J., de Pauw M., François K., van
Caenegem O., Ancion A., Van Cleemput J., Milicic D., Moza A., Schenker
P., Röhrich L., Schönrath F., Thul J., Steinmetz M., Schmack B.,
Ruhparwar A., Warnecke G., Rojas S.V., Sandhaus T., Haneya A., Eifert
S., Welp H., Ablonczy L., Wagner F., Westermann D., Bernhardt A.M.,
Knappe D., Blankenberg S., Kirchhof P., Zengin E., Sinning C.
Clinical
characteristics and outcomes of patients with adult congenital heart
disease listed for heart and heart-lung transplantation in the
Eurotransplant region.
The
Journal of Heart and Lung Transplantation 39 (11),
1238-1249 (2020).
https://www.jhltonline.org/article/S1053-2498(20)31663-6/abstract
|
349.
|
Doevelaar
A., Seibert F., Bauer F., Stervbo U., Anft M., Rohn B., Winnekendonk
G., Dittmer U., Schenker P., Amann K., Zgoura P., Viebahn R., Babel N.,
Westhoff T.
Allograft
infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney
transplant recipient.
Transplant
International 33 (S2), 21
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
348.
|
Doevelaar
A.A.N., Hölzer B., Seibert F.S., Bauer F., Stervbo U., Rohn B.J.,
Zgoura P., Schenker P., Vonbrunn E., Amann K., Viebahn R., Babel N.,
Westhoff T.H.
Lessons for the
clinical nephrologist: recurrence of nephrotic syndrome induced by
SARS-CoV-2.
Journal
of Nephrology 33 (6),
1369-1372 (2020).
https://link.springer.com/article/10.1007/s40620-020-00855-5
|
347.
|
Grzella
S., Hinzmann J., Pillokeit N., Westhoff T., Viebahn R., Schenker P.
Static preservation
in pancreas transplantation: no benefits for UW even if cold ischemia
time is more than 12 hours.
Transplant
International 33 (S2), 36
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
346.
|
Hinzmann
J., Grzella S., Lengenfeld T., Pillokeit N., Hummels M., Vaihinger
H.M., Westhoff T.H., Viebahn R., Schenker P.
Impact
of donor cardiopulmonary resuscitation on the outcome of simultaneous
pancreas-kidney transplantation-a retrospective study.
Transplant
International 33 (6),
644-656 (2020).
https://onlinelibrary.wiley.com/doi/full/10.1111/tri.13588
|
345.
|
Janssen
N., Viebahn R., Das M., Seiffert P., Tröbs R.B.
Abklärung des
akuten Abdomens.
Pädiatrische
Praxis 93,
675-680 (2020).
Link
zum PDF (kostenpflichtig) |
344.
|
Lengenfeld
T., Ebeling G., Pillokeit N., Wunsch A., Westhoff T., Viebahn R.,
Schenker P.
Outcome of kidney
transplantation from living donors with multiple renal artery grafts
versus single renal artery grafts.
Transplant
International 33 (S2),
31-32 (2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
343.
|
Mehrabi
A., Kulu Y., Sabagh M., Khajeh E., Mohammadi S., Ghamarnejad O., Golriz
M.,
Morath C., Bechstein W. O., Berlakovich G. A., Demartines N., Duran M.,
Fischer
L., Guerke L., Klempnauer J., Koenigsrainer A., Lang H., Neumann U. P.,
Pascher
A., Paul A., Pisarski P., Pratschke J., Schneeberger S., Settmacher U.,
Viebahn
R., Wirth M., Wullich B., Zeier M., Buechler M. W.
Consensus on definition and
severity grading of lymphatic complications
after kidney transplantation.
British Journal of Surgery 107
(7), 801-811 (2020).
https://doi.org/10.1002/bjs.11587 |
342.
|
Ohlmeier M., Filitarin S., Delgado G.,
Frings J., Abdelaziz H., Salber J., Frommelt L., Gehrke T., Citak M.
Improved treatment
strategies can result
in better outcomes following one-stage exchange surgery for MRSA
periprosthetic
joint infection.
Journal of Medical
Microbiology 69 (8),
1100-1104 (2020).
https://doi.org/10.1099/jmm.0.001229
|
341.
|
Pacharra
S., McMahon S., Duffy P., Basnett P., Yu W., Seisel
S., Stervbo U., Babel N., Roy I., Viebahn R., Wang W., Salber J.
Cytocompatibility
Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone
Copolymer Biomaterials for Cardiovascular Applications.
Frontiers in
Bioengineering and Biotechnology 8, No. 991 (2020).
https://doi.org/10.3389/fbioe.2020.00991 |
340.
|
Piarali S., Marlinghaus L.,
Viebahn R., Lewis H., Ryadnov M. G., Groll J., Salber J., Roy I.
Activated
Polyhydroxyalkanoate Meshes
Prevent Bacterial Adhesion and Biofilm Development in Regenerative
Medicine
Applications.
Frontiers in
Bioengineering and
Biotechnology 8, No. 442 (2020).
https://doi.org/10.3389/fbioe.2020.00442 |
339.
|
Pillokeit
N., Lengenfeld T., Grzella S., Michalski S., Westhoff T., Viebahn R.,
Schenker P.
Percutaneous
pancreas graft biopsies - feasibility, results and complications.
Transplant
International 33 (S2), 36
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
338.
|
Quast
L.S., Grzella S., Lengenfeld T., Pillokeit N., Hummels M., Zgoura P.,
Westhoff T.H., Viebahn R., Schenker P.
Outcome of kidney
transplantation using organs from brain-dead donors older than 75 years.
Transplantation
Proceedings 52 (1),
119-126 (2020).
https://doi.org/10.1016/j.transproceed.2019.11.013 |
337.
|
Rump K., Rahmel T.,
Rustige A.-M., Unterberg M., Nowak H., Koos B., Schenker P., Viebahn
R.,
Adamzik M., Bergmann L.
The Aquaporin 3
Promoter
Polymorphism-1431 A/G is Associated with Acute Graft Rejection and
Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune
Cell
Migration.
Cells 9 (6), (2020).
https://doi.org/10.3390/cells9061421 |
| 336. |
Spiliotis A. E., Spiliotis P.M., Palios I.M.
Transferability of Simulation-Based Training in Laparoscopic Surgeries: A Systematic Review.
Minimally Invasive Surgery (2020).
https://doi.org/10.1155/2020/5879485 |
335.
|
Stervbo U., Bajda S.,
Wehler P., Rohn B. J., Streichhahn M., Temizsoy S., Kohut E., Roch T.,
Viebahn
R., Westhoff T.H., Babel N.
Stability of 12
T-helper cell-associated
cytokines in human serum under different pre-analytical conditions.
Cytokine 129, 155044 (2020).
https://doi.org/10.1016/j.cyto.2020.155044
|
334.
|
Stervbo U., Nienen M.,
Hecht J., Viebahn R., Amann K., Westhoff T. H., Babel N.
Differential Diagnosis of
Interstitial
Allograft Rejection and BKV Nephropathy by T-cell Receptor Sequencing.
Transplantation
104 (4), E107-E108
(2020).
Link
zum PDF |
333.
|
Suesal C., Kumru G.,
Doehler B., Morath C., Baas M., Lutz J., Unterrainer C., Arns W.,
Aubert O.,
Bara C., Beiras-Fernandez A., Boehmig G. A., Boesmueller C., Diekmann
F.,
Dutkowski P., Hauser I., Legendre C., Lozanovski V.J., Melk A., Minor
T.,
Mueller T.F., Pisarski P., Rostaing L., Schemmer P., Schneeberger S.,
Schwenger V., Sommerer C., Toenshoff B., Viebahn R., Viklicky O.,
Weimer R.,
Weiss K.-H., Zeier M., Zivcic-Cosic S., Heemann U.
Should kidney
allografts from old donors
be allocated only to old recipients?
Transplant
International 33 (8), 849-857 (2020).
https://doi.org/10.1111/tri.13628
|
332.
|
Suwelack B.,
Thaiss F., Sommerer C., Dragun D., Hauser I.A., Witzke O., Hugo C.,
Schenker P., Merville P., Kamar N., Kroeger I., Junge M., Nashan B.
Country-dependent
outcome differences after kidney transplantation in France vs. Germany
- an additional analysis of the athena study.
Transplantation
104 (S3),
S32 (2020).
https://journals.lww.com
|
331.
|
Thaiss
F., Sommerer C., Suwelack B., Dragun D., Hauser I.A., Witzke O., Hugo
C., Schenker P., Kamar N., Merville P., Kroeger I., Junge M., Nashan B.
ATHENA - Patient
and Allograft Outcome Differences after Kidney Transplantation -
Germany vs. France.
American Journal of Transplantation 20 (S3), 445-446
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajt.16170
|
330.
|
Thieme
C., Schulz M., Roch T., Wehler P., Amini L., Viebahn R., Choi M.,
Schmueck-Henneresse M., Reinke P., Westhoff T., Babel N.
EBV-associated
post-transplant lymphoproliferative disorder: in vitro model for a
rational modification of immunosuppression.
Transplant
International 33 (S2), 19
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
329.
|
Thiesen D.M., Mumin-Gunduz S., Gehrke T., Klaber I., Salber J., Suero
E., Citak M.
Synchronous Periprosthetic Joint
Infections The Need for All Artificial Joints to Be Aspirated Routinely.
Journal of Bone and
Joint Surgery-American Volume 102 (4), 283-291
(2020).
https://europepmc.org/article/med/31855870
|
328.
|
Varela
P., Marlinghaus L., Sartori S., Viebahn R., Salber J., Ciardelli, G.
Response of Human
Macrophages to Clinically Applied Wound Dressings Loaded With Silver.
Frontiers
in Bioengeneering and Biotechnology 8, 1-13
(2020).
https://doi.org/10.3389/fbioe.2020.00124
|
327.
|
Waldecker
C., Seibert F., Zgoura P., Wunsch A., Schenker P., Bauer F., Rohn B.,
Viebahn R., Babel N., Westhoff T.
Predictors of
rejection on renal transplant recipients undergoing protocol biopsy for
de novo donor specific antibodies.
Transplant
International 33 (S2), 29
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
326.
|
Westhoff T.H, Seibert F.
S., Bauer F., Stervbo U., Anft M., Doevelaar A.A.N., Rohn B.J.,
Winnekendonk
G., Dittmer U., Schenker P., Vonbrunn E., Amann K., Viebahn R., Babel N.
Allograft infiltration
and
meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant
recipient.
American Journal of
Transplantation 20 (11),
3216-3220 (2020).
https://doi.org/10.1111/ajt.16223 |
325.
|
Zgoura
P., Seibert F.S., Waldecker C., Doevelaar A., Bauer F., Rohn B.,
Schenker P., Wunsch A., Viebahn R., Babel N., Westhoff T.H.
Psychological
Responses to the Coronavirus Disease 2019 Pandemic in Renal Transplant
Recipients.
Transplantation
Proceedings 52 (9),
2671-2675 (2020).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470883/
|
324.
|
Zgoura P., Waldecker C.,
Bauer F., Seibert F.S, Rohn B., Schenker P., Wunsch A., Hajt S.,
Viebahn R.,
Babel N., Westhoff T.H.
Vaccination Against
Urinary Tract
Infection After RenalTransplantation.
Transplantation
Proceedings 52 (10),
3192-3169 (2020).
https://doi.org/10.1016/j.transproceed.2020.06.018
|
323.
|
Zgoura P., Waldecker C., Doevelaar A., Wunsch
A., Schenker P., Seibert F., Rohn B., Bauer F., Viebahn R., Babel N.,
Westhoff T.
Psychological
responses to the COVID-19 pandemic in renal transplant recipients.
Transplant
International 33 (S2),
22-23 (2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
322.
|
Zgoura
P., Waldecker C., Seibert F., Wunsch A., Schenker P., Rohn B., Bauer
F., Viebahn R., Babel N., Westhoff T.
Vaccination against
urinary tract infection after renal transplantation.
Transplant
International 33 (S2), 28
(2020).
https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13733
|
321.
|
Abdelaziz
H., Gruber H., Gehrke T., Salber J., Citak M.
What are the
factors associated with re-revision after one-stage revision for
periprosthetic joint infection of the hip? A case-control study.
Clinical
Orthopaedics and Related Research 477 (10),
2258-2263 (2019).
https://doi.org/10.1097/corr.0000000000000780
|
320.
|
Anft
M., Roch T., Wehler P., Stervbo U., Viebahn R., Westhoff T., Choi M.,
Babel N.
mTOR
inhibitor-based immunosuppression is associated with a higher frequency
of ifn gamma-producing ebv-specific cd4 (+) t cells as compared to mtor
inhibitor-free therapy in kidney transplant patients.
Transplant
International 32 (S2), 140
(2019).
Link zum PDF |
319.
|
Anft
M., Stervbo U., Nienen M., Skrzypczyk S., Seibert F., Durr M., Bauer
F., Viebahn R., Westhoff T., Babel N.
Effect of rapamycin
and bortezomib treatment on the cellular immunity in kidney transplant
patients with humoral rejection.
Transplant
International 32 (S2), 203
(2019).
Link zum PDF |
318.
|
Anft
M., Roch T., Wehler P., Stervbo U., Viebahn R., Westhoff T.H., Choi M.,
Babel N.
mTOR
inhibitor-based immunosuppression is associated with a higher frequency
of ifn gamma-producing ebv-specific cd4 (+) t cells as compared to mtor
inhibitor-free therapy in kidney transplant patients.
Transplant
International 32 (S3), 12
(2019).
Link zum PDF |
317.
|
Anft
M., Stervbo U., Nienen M., Skrzypczyk S., Seibert F.S., Durr M., Bauer
F., Viebahn R., Westhoff T.H., Babel N.
Effect of rituximab
and bortezomib treatment on the cellular immunity in kidney transplant
patients with humoral rejection.
Transplant
International 32 (S3), 21
(2019).
Link zum PDF |
316.
|
Babel
S., Roch T., Anft M., Stervbo U., Wehler P., Viebahn R., Westhoff
T.H., Babel N., Schmuck-Henneresse M.
BKV-specific
cellular immunity demonstrates a cd4 (+) t cell restriction that is not
due to limitations in cd8 (+) t cell detection assay.
Transplant
International 32 (S2), 279
(2019).
Link zum PDF |
315.
|
Babel
S., Roch T., Anft M., Stervbo U., Wehler P., Viebahn R., Westhoff T.H.,
Schmück-Henneresse M., Babel N.
BKV-specific
cellular immunity demonstrates a cd4 (+) t cell restriction that is not
due to limitations in cd8 (+) t cell detection assay.
Transplant
International 32 (S3), 28
(2019).
Link zum PDF |
314.
|
Bauer
F., Pagonas N., Seidel M.,Doevelaar A., Seibert F.S., Klein T., Viebahn
R., Babel N., Westhoff T.H.
Application of new
hypertension guidelines to renal transplant recipients: impact on
cardiovascular outcome and graft survival.
Transplant
International 32 (S2), 71
(2019).
Link zum PDF |
313.
|
Bertram
S., Seidel M., Waldecker C.B., Rohn B., Bauer F., Viebahn R., Westhoff
T.H., Babel N., Seibert F.S.
De novo
donor-specific antibody formation after conversion from calcineurin
inhibitor to everolimus vs. Sirolimus in renal transplant recipients.
Transplant
International 32 (S3), 45
(2019).
Link zum PDF |
312.
|
Blazquez-Navarro
A., Bauer C., Sawitzki B., Viebahn R., Westhoff T.H., Reinke P.,
Thomusch O., Hugo C., Or-Guil M., Babel N.
Risk factors of
epstein-barr virus reactivation and post-transplant lymphoproliferative
disorders during the first year after kidney transplantation: results
from a large multi-centre study.
Transplant
International 32 (S2), 392
(2019).
Link zum PDF |
311.
|
Blazquez-Navarro
A., Bauer C., Sawitzki B., Westhoff T.H., Viebahn R., Reinke P.,
Thomusch O., Hugo C., Or-guil M., Babel N.
Prophylactic
strategy against cytomegalovirus is associated with inferior kidney
function in transplant patients.
Transplant International
32 (S2), 138
(2019).
Link zum PDF |
310.
|
Blazquez-Navarro A.,
Silberreis K., Muskes A., Thieme C., Dernedde J.,
Seibert F., Bauer F., Viebahn R., Roch T., Westhoff T.H., Babel N.
Peritransplant
complement factor c5a level as a potential prediction marker for
delayed graft function.
Transplant
International 32 (S2), 406
(2019).
Link zum PDF |
309.
|
Citak
M., Friedenstab J., Abdelaziz H., Suero E.M., Zahar A., Salber J.,
Gehrke T.
Risk Factors for
Failure After 1-Stage Exchange Total Knee Arthroplasty
in the Management of Periprosthetic Joint Infection.
The
Journal of Bone and Joint Surgery. American Volume 101 (12),
1061-1069 (2019).
https://doi.org/10.2106/jbjs.18.00947
|
308.
|
Hinzmann
J., Grzella S., Lengenfeld T., Pillokeit N., Viebahn R., Schenker P.
Impact of donor
cardiopulmonary resuscitation on the outcome of
simultaneous pancreas kidney transplantation (spk).
Transplant
International 32 (S3), 13
(2019).
Link zum PDF |
307.
|
Kogut
V., Grzella S., Lengenfeld T., Pillokeit N., Viebahn R., Schenker P.
Complications after
pancreas transplantations with exocrine drainage
through a duodenoduodenostomy vs. Duodenojejunostomy.
Transplant
International 32 (S3), 41
(2019).
Link zum PDF |
306.
|
Legendre
C., Viebahn R., Crespo M., Dor F., Gustafsson B., Samuel U., Karam V.,
Binet I., Aberg F., De Geest S., Moes D.J.A.R., Tonshoff B.,
OppenheimerF., Asberg A., Halleck F., Loupy A., Suesal C.
Beyond Survival in
Solid Organ Transplantation: A Summary of Expert
Presentations from the Sandoz 6th Standalone Transplantation Meeting,
2018.
Transplantation
103 (S9),
S1-S13 (2019).
https://doi.org/10.1097/tp.0000000000002846
|
305.
|
Pacharra
S., Ortiz R.,
McMahon S., Wang W., Viebahn R., Salber J., Quintana I.
Surface patterning of a novel
PEG-functionalized poly-l-lactide polymer to improve its
biocompatibility:
Applications to bioresorbable vascular stents.
Journal
of Biomedical Materials
Research Part B-Applied Biomaterials 107
(3), 624-634 (2019).
https://doi.org/10.1002/jbm.b.34155
|
304.
|
Pagonas
N., Bauer F., Seibert F.S,, Seidel M., Schenker P., Kykalos S., Dürr
M., Reinke P., Babel N., Viebahn R., Westhoff T.H
Intensive blood
pressure control is associated with improved patient
and graft survival after renal transplantation.
Scientific
Reports 9
(1), 10507 (2019).
https://doi.org/10.1038/s41598-019-46991-2
|
303.
|
Pagonas
N., Markakis K., Bauer F., Seibert F.S., Seidel M., Zidek W., Kykalos
S., Sasko B., Klein T., Babel N., Viebahn R., Westhoff T.H.
The impact of blood
pressure variability and pulse pressure on graft
survival and mortality after kidney transplantation.
Clinical
Transplantation 33 (1),
13448 (2019).
https://doi.org/10.1111/ctr.13448 |
302.
|
Pagonas
N., Yusefi K.,
Seibert F. S., Bauer F., Markakis K., Sasko B., Zidek W., Goetze T.,
Schlattmann P., Viebahn R., Babel N., Westhoff T.H.
Effects of late
cyclosporine withdrawal
on renal graft function and survival.
Journal of
Nephrology 32 (2), 315-321 (2019).
https://doi.org/10.1007/s40620-018-0554-7 |
301.
|
Rahmel
T., Nowak H., Rump K., Koos B., Schenker P., Viebahn R., Adamzik M.,
Bergmann L.
The aquaporin
5-1364A/C promoter polymorphism is associated with
cytomegalovirus infection risk in kidney transplant recipients.
Frontiers in Immunology 10, 2871 (2019).
https://doi.org/10.3389/fimmu.2019.02871
|
300.
|
Sommerer
C., Suwelack B., Dragun D., Schenker P., Hauser I.A., Witzke O., Hugo
C., Kamar N., Merville P., Junge M., Thaiss F., Nashan B.; Athena Study
Group.
An open-label,
randomized trial indicates that everolimus with
tacrolimus or cyclosporine is comparable to standard immunosuppression
in de novo kidney transplant patients.
Kidney
International 96 (1),
231-244 (2019).
https://doi.org/10.1016/j.kint.2019.01.041
|
299.
|
Thieme
C., Schulz M., Roch T., Wehler P., Amini L., Choi M., Viebahn R.,
Schmuck-Henneresse M., Reinke P., Westhoff T., Babel N.
EBV-associated
post-transplant lymphoproliferative disorder: in vitro
model for a rational modification of immunosuppression.
Transplant
International 32 (S2), 406
(2019).
Link zum PDF |
298.
|
Thiesen
D.M., Koniker A., Gehrke T., Linke P., Ohlmeier M., Salber J., Citak M.
The impact of
alpha-defensin test in diagnosing periprosthetic
infection after total ankle arthroplasty.
Journal
of Foot & Ankle Surgery 58 (6),
1125-1128 (2019).
https://doi.org/10.1053/j.jfas.2019.03.006
|
297.
|
Unter
Ecker N., Koniker A., Gehrke T., Salber J., Zahar A., Hentschke M.,
Citak M.
What is the
diagnostic accuracy of alpha-defensin and leukocyte
esterase test in periprosthetic shoulder infection?
Clinical
Orthopaedics and Related Research 477 (7),
1712-1718 (2019).
https://doi.org/10.1097/corr.0000000000000762
|
296.
|
Varela
P., Sartori S., Viebahn R., Salber J., Ciardelli G.
Macrophage
immunomodulation: An indispensable tool to evaluate the
performance of wound dressing biomaterials.
Journal
of Applied Biomaterials & Functional Materials 17 (1),
(2019).
https://doi.org/10.1177/2280800019830355
|
295.
|
Waldecker C.B., Wunsch
A., Schenker P., Seibert FS., Bauer F., Babel N., Rohn B., Viebahn R.,
Westhoff T.H.
Biopsy findings
after detection of de novo donor specific antibodies in
renal transplant recipients - a single center experience.
Transplant
International 32 (S3), 41
(2019).
Link zum PDF |
294.
|
Weisner J., Landel I.,
Reintjes C.,
Uhlenbrock N., Trajkovic-Arsic M., Dienstbier N., Hardick J., Ladigan
S., Lindemann M., Smith S., Quambusch L., Scheinpflug R., Depta L.,
Gontla R., Unger A., Muller H., Baumann M., Schultz-Fademrecht C.,
Gunther G., Maghnouj A., Muller MP., Pohl M., Teschendorf C., Wolters
H., Viebahn R., Tannapfel A., Uhl W., Hengstler JG., Hahn SA., Siveke
JT., Rauh D.
Preclinical
efficacy of covalent-allosteric AKT inhibitor borussertib
in combination with trametinib in kras-mutant pancreatic and colorectal
cancer.
Cancer
Research 79 (9),
2367-2378 (2019).
https://doi.org/10.1158/0008-5472.can-18-2861
|
293.
|
Apel C., Buttler P., Salber
J., Dhanasingh A., Neuss S.
Differential
mineralization of human dental pulp stem cells on diverse polymers.
Biomedical
Engineering-Biomedizinische Technik 63
(3), 261-269 (2018).
https://doi.org/10.1515/bmt-2016-0141
|
292.
|
Ayami
M.S., Grzella S., Kykalos S., Viebahn R., Schenker P.
Pancreas Donor Risk
Index but Not Pre-Procurement Pancreas Allocation Suitability Score
Predicts Pancreas Graft Survival: A Cohort Study from a Large German
Pancreas Transplantation Center.
Annals
of Transplantation 23, 434-441
(2018).
https://doi.org/10.12659/aot.910014
|
291.
|
Bauer
F., Seidel M., Pagonas N., Seibert F. S., Rohn B., Viebahn R., Babel
N., Westhoff T. H.
Association of
Serum Uric Acid Concentration with Intrarenal Resistance Index and
Allograft Function after Renal Transplantation.
Transplant
International 31 (S5), 32
(2018).
Link zum Verlag
|
290.
|
Bauer
J., Grzella S., Bialobrzecka M., Berger L., Westhoff T.H., Viebahn R.,
Schenker P.
Success of Kidney
Transplantations From Deceased Donors with Acute Kidney Injury.
Annals
of Transplantation 23, 836-844
(2018).
https://doi.org/10.12659/aot.912660
|
289.
|
Berger
L., Bialobrzecka M., Hummels M., Wunsch A., Viebahn R., Schenker P.
Successful Combined
Pancreas-Kidney-Transplantation after Pre-Transplant Back-Table
Thrombectomy of the Splenic Vein.
Transplant
International 31 (S5), 39
(2018).
Link zum PDF
|
288.
|
Berger
L., Bialobrzecka M., Schenker P., Wunsch A., Viebahn R.
Complications after
Pancreas Transplantation.
Transplantation
102 (S1-Suppl. 7),
S753 (2018).
Link zum PDF
|
287.
|
Bialobrzecka
M., Berger L., Wunsch A., Schenker P., Viebahn R.
New Tool Helping
Differentiation Between Rejection and Graft Pancreatitis.
Transplantation
102 (S1-Suppl. 7),
S448 (2018).
Link zum PDF
|
286.
|
Bialobrzecka
M., Wunsch A., Schenker P., Berger L., Viebahn R.
A Fatal Course
after Combined Pancreas Kidney Transplantation from a Donor with
HELLP-Syndrome.
Transplantation
102 (S1-Suppl. 7),
S749 (2018).
Link zum PDF
|
285.
|
Blazquez-Navarro
A., Dang-Heine C., Bauer C., Wittenbrink N., Wolk K., Sabat R.,
Westhoff T. H., Sawitzki B., Viebahn R., Reinke P., Or-Guil M.,
Thomusch O., Hugo C., Babel N.
Risk Factors of
Epstein-Barr Virus Reactivation and Post-Transplant Lymphoproliferative
Disorders in the First Year after Kidney Transplantation: Results from
a Large Multicentre Study.
Transplant
International 31 (S5), 22
(2018).
Link zum PDF
|
284.
|
de
Bakker H., Grzella S., Bialobrczecka M., Berger L., Wunsch A., Viebahn
R., Schenker P.
Preemptive Versus
Non-Preemptive Simultaneous Pancreas-Kidney Transplantation: A
Comparative Analysis of Long-Term Results.
Transplant
International 31 (S5), 13
(2018).
Link zum PDF
|
283.
|
Dragun
D., Suwelack B., Sommerer C., Hauser I.A., Witzke O., Hugo C., Kamar
N., Merville P., Schenker P., Junge M., Thaiss F., Nashan B.
Significant
Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to
Standard Tacrolimus-MPA Regimen in de Novo Kidney Transplant
Recipients: Athena 12 months Data on Infections.
Transplantation
102, S128
(2018).
Link zum PDF
|
282.
|
Dralle
H., Kols K., Witzigmann H., Viebahn R.
Primärtherapie des
Analkarzinoms. [The
Primary Treatment of Anal Cancer].
Der
Chirurg 89
(2), 152-154
(2018).
https://doi.org/10.1007/s00104-017-0573-2 |
281.
|
Hauser
A., Sommerer C., Suwelack B., Dragun D., Witzke O., Hugo C., Kamar N.,
Merville P., Schenker P., Junge M., Thaiss F., Nashan B.
Significant
Anti-CMV/BKV Effect of a Modern Everolimus-Based Regimen Comparted to a
Standard Tacrolimus-MPA Regimen in De Novo Kidney Transplant
Recipients: Athena 12 Months Data on Infections.
American
Journal of Transplantation 18 (S4), 318
(2018).
Link zum PDF
|
280.
|
Idrees
A., Chiono V., Ciardelli G., Shah S., Viebahn R., Zhang X., Salber J.
Validation of In
Vitro Assays in Three-Dimensional Human Dermal Constructs.
International
Journal of Artificial Organs 41 (11),
779-788 (2018).
https://doi.org/10.1177/0391398818775519
|
| 279. |
Kamar
N., Merville P., Sommerer C., Suwelack B., Dragun D., Hauser I.A.,
Schenker P., Witzke O., Hugo C., Junge M., Nashan B., Thaiss F.
12 Months Data on
Infections From Athena Study Show Significantly Less CMV-and BKV-Events
with Everolimus-Based Versus Tacrolimus-MPA Regimen in De Novo Renal
Transplant Recipients.
Transplant
International 31 (S1), 14
(2018). |
278.
|
Kamar
N., Merville P., Suwelack B., Sommerer C., Dragun D., Hauser I.A.,
Schenker P., Witzke O., Hugo C., Junge M., Thaiss F., Nashan B.
12 Months Safety
and Efficacy Data from Athena Study on Everolimus-Based vs
Tacrolimus-MPA Regimen in De Novo Kidney Transplant Recipients.
Transplant
International 31 (S1), 14
(2018).
Link zum PDF
|
277.
|
Kogut
V., Pillokeit N., Grzella S., Wunsch A., Viebahn R., Schenker P.
Pancreas
Transplantation Using Duodenoduodenostomy: Management of Duodenal
Complications in Patients after Graft Pancreatectomy.
Transplant
International 31 (S5), 13
(2018).
Link zum PDF
|
276.
|
Legendre
C., Viebahn R., Fehrman-Ekholm I., Masnou N., Berenguer M., Potena L.,
Wennberg L., O'Grady J., Epailly E., Diekmann F., Binet I., Schwenger
V., Kuypers D., Guthoff M.
Long-term
Challenges after Solid Organ Transplantation: Summary of Expert
Presentations from the Sandoz 5th Standalone Transplantation Meeting,
2017.
Transplantation
102 (9S1
Suppl 1), S1-S14 (2018).
Link zum PDF
|
275.
|
McMahon
S., Bertollo N., Cearbhaill E.D.O., Salber J., Pierucci L., Duffy P.,
Duerig T., Bi V., Wang W.X.
Bio-resorbable
polymer stents: a review of material progress and prospects.
Progress
in Polymer Science 83, 79-96
(2018).
https://doi.org/10.1016/j.progpolymsci.2018.05.002
|
274.
|
Merville
P., Kamar N., Dragun D., Sommerer C., Suwelack B., Schenker P., Hauser
I.A., Witzke O., Hugo C., Junge M., Thaiss F., Nashan B.
12 Months Outcomes
on Allograft Function with Everolimus-CNI vs Tacrolimus-MPA Regimen in
De Novo Renal Transplant Recipients: The Athena Study.
Transplant
International 31 (S1), 15
(2018).
Link zum PDF
|
273.
|
Michita
R.T., Bogo Chies J.A., Schramm S., Horn P.A., Heinemann F.M., Wunsch
A., Viebahn R., Schenker P., Rebmann V.
A Valine Mismatch
at Position 129 of MICA is an Independent Predictor of Cytomegalovirus
Infection and Acute Kidney Rejection in Simultaneous Pancreas-Kidney
Transplantation Recipients.
International
Journal of Molecular Sciences 19, 9 (2018).
https://doi.org/10.3390/ijms19092618
|
272.
|
Müskes
A., Wehler P., Viebahn R., Westhoff T. H., Toralf R., Babel N.
Urine-Derived Renal
Epithelial Cells Secrete Chemokines in Response to Bacterial, Viral,
and Endogenous Inflammatory Stimuli.
Transplant
International 31 (S5), 30
(2018).
Link zum PDF
|
271.
|
Nashan
B., Sommerer C., Suwelack B., Dragun D., Hauser I. A., Schenker P.,
Witzke O., Hugo C., Kamar N., Merville P., Junge M., Thaiss F.
Impact of Deceased
Donor Age on the Outcome of Kidney Allograft Function - An Analysis
from the Athena Trial.
Transplant
International 31 (S5), 18
(2018).
Link zum PDF
|
270.
|
Nashan
B., Sommerer C., Suwelack B., Dragun D., Hauser I.A., Witzke O., Hugo
C., Kamar N., Merville P., Schenker P., Junge M., Thaiss F.
The Athena Study:
12 Months Safety and Efficacy Data for Everolimus Combined with
Tacrolimus or Cyclosporine Compared to a Standard
Tacrolimus-Mycophenolate Regimen in de Novo Kidney Transplant Patients.
Transplantation
102, S279
(2018).
Link zum PDF
|
269.
|
Nashan
B., Sommerer C., Suwelack B., Dragun D., Witzke O., Hugo C., Kamar N.,
Merville P., Hauser A., Schenker P., Junge M., Thaiss F.
Allograft Function
after 12 Months with Everolimus Plus Either Tacrolimus or Cyclosporine
Compared to a Standard Regimen of Tacrolimus with MPA in De Novo Renal
Transplant Recipients: The Athena Study.
American
Journal of Transplantation 18 (S4), 260
(2018).
Link zum PDF
|
268.
|
Pagonas
N., Seibert F. S., Bauer F., Doevelaar A., Klein T., Babel N., Viebahn
R., Westhoff T. H.
Application of New
Hypertension Guidelines to Renal Transplant Recipients: Impact on
Cardiovascular Outcome and Graft Survival.
Journal
of Hypertension 36 (1), E290
(2018). |
267.
|
Pagonas
N., Seibert F. S., Bauer F., Doevelaar A., Klein T., Babel N., Viebahn
R., Westhoff T. H.
Application of New
Hypertension Guidelines to Renal Transplant Recipients: Impact on
Cardiovascular Outcome and Graft Survival.
Transplant
International 31 (S5), 29
(2018).
|
266.
|
Proneth
A., Schnitzbauer A.A., Schenker P., Wunsch A., Rauchfuss F., Arbogast
H., Manekeller S., Nadalin S., Heise M., Ströhlein M.A., Banas B.,
Schemmer P., Becker T., Bechstein W.O., Pascher A., Viebahn R.,
Geissler E.K., Schlitt H.J., Farkas S.A.
Extended Pancreas
Donor Program - The EXPAND Study A Prospective Multicenter Trial
Testing the Use of Pancreas Donors Over Age 50.
Transplantation
102 (8),
1330-1337 (2018).
Link zum PDF
|
265.
|
Rummo
O.O., Carmellini M., Rostaing L., Oberbauer R., Christiaans M.H.,
Mousson C., Langer R.M., Citterio F., Charpentier B., Brown M., Kazeem
G., Lehner F.; ADHERE study investigators.
ADHERE:
randomized controlled trial comparing renal function in de novo kidney
transplant recipients receiving prolonged-release tacrolimus plus
mycophenolate mofetil or sirolimus.
Transplant
International 30 (1),
83-95 (2017).
https://doi.org/10.1111/tri.12878
|
264.
|
Schenker
P., Sommerer C., Suwelack B., Dragun D., Hauser I.A., Witzke O., Hugo
C., Kamar N., Merville P., Junge M., Thaiss F., Nashan B.
Outcomes on
Allograft Function after 12 Months with Everolimus Plus Either
Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-MPA
Regimen in De Novo Renal Transplant Recipients: The Athena Study.
Transplantation
102, S280
(2018).
Link zum PDF
|
263.
|
Schulte
K., Borzikowsky C., Rahmel A., Kolibay F., Polze N., Frankel P., Mikle
S., Alders B., Kunzendorf U., Feldkamp
T.
Decline in Organ
Donation in Germany A Nationwide Secondary Analysis of All Inpatient
Cases.
Deutsches
Ärzteblatt International 115 (27-28),
463-468 (2018).
|
262.
|
Stamopoulos
P., Viebahn R., Schenker P.
Duodenocolostomy as
Treatment of Ileus in Short Bowel Syndrome: A Case Report.
American
Journal of Case Reports 19, 796-799
(2018).
|
261.
|
Suwelack
B., Sommerer C., Dragun D., Witzke O., Hugo C., Kamar N., Merville P.,
Hauser A., Schenker P., Junge M., Nashan B., Thaiss F.
The ATHENA Study:
12 Months Safety and Efficacy Data from Everolimus Combined with
Tacrolimus or Cyclosporine Compared to a Standard
Tacrolimus-Mycophenolate Regimen in De Novo Kidney Transplant Patients.
American
Journal of Transplantation 18 (S4),
259-260 (2018).
|
260.
|
Thaiss
F., Sommerer C., Suwelack B., Dragun D., Hauser I. A., Witzke O., Hugo
C., Schenker P., Kamar N., Merville P., Junge M., Nashan B.
European Kidney
Transplant Trial Athena - Patient and Allograft Outcome by Country.
Transplant
International 31 (S5), 18
(2018).
|
259.
|
Wunsch
A., Niess I., Bialobrzecka M., Hummels M., Berger L., Schenker P.,
Viebahn R.
Development of the
Waiting Time for a Pancreas Transplant over the Last 11 Years: A Center
Analysis.
Transplant
International 31 (S5), 13
(2018).
|
258.
|
Al-Batran
S.E., Goetze T.O., Mueller D.W., Vogel A., Winkler M., Lorenzen S.,
Novotny A., Pauligk C., Homann N., Jungbluth T., Reissfelder C., Caca
K., Retter S., Horndasch E., Gumpp J., Bolling C., Fuchs K.H., Blau W.,
Padberg W., Pohl M., Wunsch A., Michl P., Mannes F., Schwarzbach M.,
Schmalenberg H., Hohaus M., Scholz C., Benckert C., Knorrenschild J.R.,
Kanngießer V., Zander T., Alakus H., Hofheinz R.D., Roedel C., Shah
M.A., Sasako M., Lorenz D., Izbicki J., Bechstein W.O., Lang H., Moenig
S.P.
The
RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs.
chemotherapy followed by surgical
on survival and quality of
life in patients with limited-metastatic adenocarcinoma of the stomach
or esophagogastric junction – a phase III trial of the German
AIO/CAO-V/CAOGI.
BMC Cancer 17 (1), 893 (2017). |
257.
|
Arns
W., Huppertz A., Rath T., Ziefle S., Rump LC., Hansen A., Budde K.,
Lehner LJ., Shipkova M., Baeumer D., Kroeger I., Sieder C., Klein T.,
Schenker P.
Pharmacokinetics
and clinical outcomes of generic Tacrolimus (hexal) versus branded
Tacrolimus in de novo kidney transplant patients: a multicenter,
randomized trial.
Transplantation 101 (11), 2780-2788 (2017).
Link zum PDF |
256.
|
Bauer
J., Grzella S., Viebahn R., Schenker P.
Results
after renal transplantation from deceased donors with acute kidney
injury.
Transplant
International 30 (S4), 21
(2017). |
255.
|
Bauer
F., Pagonas N., Seibert F.S., Zidek W., Viebahn R., Babel N., Westhoff
T.H.
Serum
Uric Acid and Arterial Function After Renal Transplantation.
Annals
of Transplantation 22, 431-439 (2017). |
254.
|
Bauer
F., Pagonas N., Seibert F.S., Zidek W., Viebahn R., Babel N., Westhoff
T.H.
Serum
uric acid and arterial function after renal transplantation.
Transplant
International 30 (S4), 29
(2017). |
253.
|
Berger
L., Bialobrzecka M., Schenker P., Wunsch A., Viebahn R.
Influence
of complications on the outcome after pancreas transplantation.
Transplant
International 30 (S4), 10
(2017). |
252.
|
Bialobrzecka
M., Berger L., Wunsch A., Schenker P., Klein T., Viebahn R.
A
rare complication after retroperitoneoscopic donor nephrectomy.
Transplant
International 30 (S4), 44
(2017). |
251.
|
Dragun
D., Sommerer C., Suwelack B., Schenker P., Hauser I., Witzke O., Hugo
C., Kamar N., Merville P., Junge M., Thaiss F., Nashan B.
ATHENA
study outcomes on allograft function after 12 months with
Everolimus-CNI vs Tacrolimus-MPA regimen in de novo renal transplant
recipients.
Transplant
International 30 (2), 562
(2017). |
250.
|
Kykalos
S., Wunsch A., Klein T., Viebahn R., Schenker P.
Successful
Simultaneous Pancreas-Kidney Re-transplantation in a Highly Human
Leukocyte Antigen-Sensitized Patient.
Transplantation
Proceedings 49 (7), 1652-1655 (2017). |
249.
|
Michita
R.T., Chies J.A., Heinemann F.M., Horn P.A., Wunsch A., Schenker P.,
Viebahn R., Rebmann V.
The
contribution of MICA-129 Val/Met polymorphism on graft rejection and
CMV infection in simultaneous pancreas and kidney transplant patients -
one-year follow-up.
HLA 89 (6), 402 (2017). |
248.
|
Michita
R.T., Chies J.A.B., Heinemann FM., Wunsch A., Schenker P., Viebahn R.,
Rebmann V., Horn P.A.
The
contribution of MICA-129 Val/ Met polymorphism on graft rejection and
CMV infection in simultaneous pancreas and kidney transplant patients -
one-year follow-up.
Transfusion Medicine
and Hemotherapy 44 (1), 73
(2017). |
247.
|
Nashan
B., Sommerer C., Suwelack B., Dragun D., Hauser I., Schenker P., Witzke
O., Hugo C., Kamar N., Merville P., Junge M., Thaiss F.
Significantly
less CMV- and BKV-events with Everolimus-based vs. Tacrolimus-MPA
regimen in de novo renal transplant recipients: 12 months data on
infections from athena study.
Transplant
International 30 (S2), 162
(2017). |
246.
|
Pagonas
N., Seidel M., Bauer F., Seibert FS., Rohn B., Klein T., Wunsch A.,
Babel N., Viebahn R., Westhoff T.H.
Association
of serumucid acid lowering therapy and resistance index after renal
transplantation.
Transplant
International 30 (S4), 32
(2017). |
245.
|
Schenker
P.
Scoring
Systeme bei der Pankreasallokation. P-PASS und PDRI im Vergleich.
Current Congress (Karl
Demeter Verlag im Georg Thieme Verlag KG), 10 (2017).
Link zum Tagungsband | Artikel als PDF-Datei |
244.
|
Schmiegel
W., Scott R.J., Dooley S., Lewis W., Meldrum C.J., Pockney P., Draganic
B., Smith S., Hewitt C., Philimore H., Lucas A., Shi E., Namdarian K.,
Chan T., Acosta D., Ping-Chang S., Tannapfel A., Reinacher-Schick A.,
Uhl W., Teschendorf C., Wolters H., Stern J., Viebahn R., Friess H.,
Janssen K.P., Nitsche U., Slotta-Huspenina J., Pohl M., Vangala D.,
Baraniskin A., Dockhorn-Dworniczak B., Hegewisch-Becker S., Ronga P.,
Edelstein D.L., Jones F.S., Hahn S., Fox S.B.
Blood-based
detection of RAS mutations to guide anti-EGFR therapy in colorectal
cancer patients: concordance of results from circulating tumor DNA and
tissue-based RAS testing.
Molecular
Oncology 11 (2), 208-219 (2017). |
243.
|
Schnuelle
P., Schmitt W.H., Weiss C., Habicht A., Renders L., Zeier M., Drüschler
F., Heller K., Pisarski P., Banas B., Krämer B.K., Jung M., Lopau K.,
Olbricht C.J., Weihprecht H., Schenker P., De Fijter J.W., Yard B.A.,
Benck U.
Effects
of dopamine donor pretreatment on graft survival after kidney
transplantation: a randomized trial.
Clinical Journal of
the American Society of Nephrology 12 (3), 493-501 (2017). |
242.
|
Sommerer
C., Suwelack B., Dragun D., Schenker P., Hauser I.A., Witzke O., Hugo
C., Kamar N., Merville PG., Junge M., Nashan B., Thaiss F.
ATHENA
study: outcomes on allograft function after 12 months of modern
Everolimus-based vs. conservative Tacrolimus-MPA regimen in de novo
renal transplant recipients.
Transplant
International 30 (S4), 20
(2017). |
241.
|
Sommerer
C., Suwelack B., Dragun D., Hauser I., Schenker P., Witzke O., Hugo C.,
Kamar N., Merville P., Junge M., Nashan B., Thaiss F.
Everolimus-based
vs. Tacrolimus-MPA regimen in de novo kidney transplant recipients: 12
months safety and efficacy data from ATHENA study.
Transplant
International 30 (S2), 160
(2017). |
240.
|
Stervbo
U., Klein T., Nienen M., Viebahn R., Westhoff T.H., Babel N.
TCR
NGS based evidence for differential diagnosis and personalized therapy
in BKV nephropathy.
Transplant
International 30 (S2),
357-358 (2017). |
239.
|
Stervbo
U., Klein T., Nienen M., Viebahn R., Westhoff T.H., Babel N.
TCR
NGS based evidence for differential diagnosis and personalized therapy
in BKV nephropathy.
Transplant
International 30 (S4), 30
(2017). |
238.
|
Stervbo
U., Nienen M., Weist B., Kuchenbecker L., Wehler P., Viebahn R.,
Westhoff T.H., Reinke P., Volk HD., Babel N.
Viremia
clearance rate correlates with exhaustion state but not receptor
repertoire shape of BKV-specific t-cells in renal transplant patients
with severe BKV infection.
Transplant
International 30 (S4), 25
(2017). |
237.
|
Suwelack
B., Dragun D., Sommerer C., Schenker P., Hauser I.A., Witzke O., Hugo
C., Kamar N., Merville P.G., Junge M., Nashan B., Thaiss F.
Reduced
incidence of CMV-events with modern Everolimus-based vs conservative
Tacrolimus-MPA-based regimen in de novo renal transplant recipients: 12
months data on infections from ATHENA study.
Transplant
International 30 (S4), 15
(2017). |
236.
|
Thaiss
F., Sommerer C., Suwelack B., Dragun D., Schenker P., Hauser I.A.,
Witzke O., Hugo C., Kamar N., Merville P.G., Junge M., Nashan B.
12 Months
Data from Athena Study Show Comparable Safety and Efficacy of Modern
Everolimus-Based Regimen vs. Conservative Tacrolimus-MPA-Based Regimen
in De Novo Renal Transplant Recipients.
Transplant
International 30 (S4), 20 (2017). |
235.
|
Thieme
C., Weist B., Muskes A., Reinke P., Viebahn R., Westhoff TH., Babel N.
Monitoring
of donor-reactive t cells using donor spleen cells and/or IFNg-based
assays might underestimate donor-reactive t cell immunity.
Transplant
International 30 (S4), 20
(2017). |
234.
|
Viebahn
R.
Tumorerkrankungen
vor und nach Organtransplantation. Dringlichkeit und Erfolgsaussicht
beim onkologisch vorerkrankten Patienten.
Current
Congress (Karl Demeter Verlag im Georg
Thieme Verlag KG), 13 (2017).
Link zum Tagungsband | Artikel als PDF-Datei
|
233.
|
Wahba
R., Suwelack B., Arns W., Cakiroglu F., Eisenberger U., Feldkamp T.,
Hansen A., Ivens K., Klein T., Kribben A., Kurschat C., Lange U.,
Mühlfeld A., Nitschke M., Reuter S., Schulte K., Viebahn R., Woitas R.,
Hellmich M., Stippel D.L.
Rescue
allocation and recipient oriented extended allocation in kidney
transplantation-influence of the EUROTRANSPLANT allocation system on
recipient selection and graft survival for initially nonaccepted
organs.
Transplant
International 30
(12), 1226-1233 (2017). |
232.
|
Ziemann
M., Heßler N., König I.R., Lachmann N., Dick A., Ditt V., Budde K.,
Reinke P., Eisenberger U., Suwelack B., Klein T., Westhoff T.H., Arns
W., Ivens K., Habicht A., Renders L., Stippel D., Bös D., Sommer F.,
Görg S., Nitschke M., Feldkamp T., Heinemann F.M., Kelsch R.
Unacceptable
human leucocyte antigens for organ offers in the era of organ shortage:
influence on waiting time before kidney transplantation.
Nephrology Dialysis
Transplantation 32 (5),
880-889 (2017). |
231.
|
Arns
W., Huppertz A., Rath T., Ziefle S., Rump L., Hansen A., Baeumer D.,
Budde K., Lehner L., Klein T., Schenker P.
Comparison
of Pharmacokinetic and Clinical Outcomes of Tacrolimus Hexal (R) with
Prograf (R) Based Regimen in De Novo Kidney Transplant Recipients:
Results from the Randomized, SparTacus Study.
American
Journal of Transplantation 16 (3), 456-457 (2016). |
230.
|
Arns
W., Huppertz A., Rath T., Ziefle S., Rump L.C., Hansen A., Baeumer D.,
Budde K., Lehner L.J., Klein T., Schenker P.
Evaluation of PK
profile and clinical outcomes with Hexal (R) versus Prograf (R) in de
novo renal transplant recipients: Results from SparTacus - a
multicentre, prospective randomized study.
Transplantation
100 (7-S1),
S378-S378 (2016).
Link zum PDF |
229.
|
Assfalg
V., Hüser N, van Meel M., Haller B., Rahmel A., de Boer J., Matevossian
E., Novotny A., Knops N., Weekers L., Friess H., Pratschke J., Függer
R., Janko O., Rasoul-Rockenschaub S., Bosmans J.L., Broeders N.,
Peeters P., Mourad M., Kuypers D., Slaviček J., Muehlfeld A., Sommer
F., Viebahn R., Pascher A., van der Giet M., Zantvoort F., Woitas R.P.,
Putz J., Grabitz K., Kribben A., Hauser I., Pisarski P., Weimer R.,
Lorf T., Fornara P., Morath C., Nashan B., Lehner F., Kliem V., Sester
U., Grimm M.O., Feldkamp T., Kleinert R., Arns W., Mönch C., Schoenberg
M.B., Nitschke M., Krüger B., Thorban S., Arbogast H.P., Wolters H.H.,
Maier T., Lutz J., Heller K., Banas B., Hakenberg O., Kalus M., Nadalin
S., Keller F., Lopau K., Bemelman F.J., Nurmohamed S., Sanders J.S., de
Fijter J.W., Christiaans M., Hilbrands L., Betjes M., van Zuilen A.,
Heemann U.
High-urgency
kidney transplantation in the Eurotransplant Kidney Allocation System:
Success or waste of organs? The Eurotransplant 15-year all-centre
survey.
Nephrology,
Dialysis, Transplantation 31 (9), 1515-1522 (2016). |
228.
|
Ayami
M.S., Klein T., Kykalos S., Viebahn R., Schenker P.
PDRI
and P-PASS in pancreas transplantation which is scoring more?
Transplant
International 29 (S3), 12-13 (2016). |
227.
|
Berger
L., Bialobrzecka M., Schenker P., Wunsch A., Viebahn R.
Influence
of positive duodenal swabs on the outcome and progress after pancreas
transplantation - actual germ spectrum.
Transplant
International 29 (S3), 33 (2016). |
226.
|
Bialobrzecka
M., Berger L., Viebahn R., Wunsch A., Schenker P.
Contrast
enhanced ultrasound of the pancreas graft.
Transplant
International 29 (S3), 33 (2016). |
225.
|
Bialobrzecka
M., Viebahn R., Wunsch A., Berger L.
Stenting
of the pancreatic duct as a therapeutic option in the treatment of
pancreatic fistula after pancreas transplantation.
Transplant
International 29 (S3), 41 (2016). |
224.
|
Bolesta
K., Kühn P., Wunsch A., Viebahn R.
Long
term quality of life after combined pancreas-kidney transplantation.
Transplant
International 29 (S3), 22 (2016). |
223.
|
Grzella
S., Tischert A., Wunsch A., Viebahn R., Schenker P.
Unexpected
reason for pancreas-graft dysfunction: giant arteriovenous fistula.
Transplant
International 29 (S3), 42 (2016). |
222.
|
Pagonas
N., Seibert F., Bauer F., Markakis K., Seidel M., Zidek W., Kykalos S.,
Klein T., Viebahn R., Westhoff T.
The
impact of blood pressure variability on adverse outcomes after kidney
transplantation.
Journal of Hypertension
34 (2), E42
(2016).
|
221.
|
Pagonas
N., Seibert F., Bauer F., Seidel M., Zidek W., Kykalos S., Klein T.,
Viebahn R., Westhoff T.
The
impact of blood pressure variability on graft survival and mortality
after kidney transplantation.
Transplant
International 29 (S3), 28 (2016).
|
220.
|
Proneth
A., Schnitzbauer A.A., Holub I., Zeman F., Banas B., Viebahn R.,
Schenker P., Arbogast H., Rauchfuss F., Pascher A., Manekeller S.,
Bechstein W.O., Schemmer P., Becker T., Strohlein M.A., Heise M.,
Nadalin S., Geissler E.K., Schlitt H.J., Farkas S.A.
Extended
pancreas donor program - the EXPAND study, a prospective multicentre
trial
Transplantation 100 (7-S1),
S327 (2016).
Link zum PDF
|
219.
|
Proneth
A., Schnitzbauer A., Viebahn R., Schenker P., Arbogast H., Manekeller
S., Nadalin S., Heise M., Strohlein M., Banas B., Schemmer P., Becker
T., Bechstein W., Pascher A., Rauchfuss F., Geissler E., Schlitt H.J.,
Farkas S.
Extended
pancreas donor program - the EXPAND study: A prospective multicenter
trial testing the use of pancreas donors over age 50.
Transplant
International 29 (S3), 50 (2016). |
218.
|
Rath
T., Ziefle S., Hansen A., Rump L.C., Budde K., Lehner L., Klein T.,
Schenker P., Kroeger I., Huppertz A., Arns W.
Results
from SparTacus - a multicentre, prospective randomized study:
evaluation of pk profile and clinical outcomes with tacrolimus hexal
(r) versus prograf (r) in de novo renal transplant recipients.
Transplant
International 29 (S3), 36 (2016). |
217.
|
Schenker
P.
The
elderly pancreas transplant recipient.
Transplant
International 29 (7), 807-809 (2016). |
216.
|
Shah
S., Usta S., Stricker I., Stern J., Tannapfel A., Viebahn R.
Is an
improvement of lymphadenectomy through an intraoperative representation
of sentinel lymph nodes in rectum carcinoma patients under use of
indocyanine green possible?- A prospective study.
The
Internist 57 (1), S7-S8 (2016). |
215.
|
Sommerer
C., Suwelack B., Dragun D., Schenker P., Hauser I.A., Nashan B., Thaiss
F.
Design
and rationale of the ATHENA study--A 12-month, multicentre, prospective
study evaluating the outcomes of a de novo everolimus-based regimen in
combination with reduced cyclosporine or tacrolimus versus a standard
regimen in kidney transplant patients: study protocol for a randomised
controlled trial.
Trials
17, 92 (2016). |
214.
|
Ueberberg
S., Tannapfel A., Schenker P., Viebahn R., Uhl W., Schneider S., Meier
J.J.
Differential
expression of cell-cycle regulators in human beta-cells derived from
insulinoma tissue.
Metabolism
65
(5), 736-746 (2016). |
213.
|
Viebahn
R.
Der
Transplantationsskandal war heilsam.
Westfälisches
Ärzteblatt (6), 17 (2016).
Link zum Artikel | Artikel als PDF-Datei |
212.
|
Wunsch
A., Bialobrzecka M., Berger L., Schenker P., Tischert A., Viebahn
R.
Role
of endovascular procedures in the management of arterial complications
following pancreas transplantation
Transplant
International 29 (S3), 13 (2016). |
211.
|
Arns W., Rath T., Rump L.C., Baeumer D., Budde K.,
Schenker P.
Spartacus:
a multicentre, prospective randomised study comparing tacrolimus hexal
(r) versus prograf (r) based regimen in de novo renal transplant
recipients.
Transplant
International 28 (S2), 26 (2015). |
210.
|
Beer
M.V., Hahn K., Diederichs S., Fabry M., Singh S., Spencer S.J., Salber
J., Möller M., Shard A.G., Groll J.
Quantifying
ligand-cell interactions and determination of the surface
concentrations of ligands on hydrogel films: The measurement challenge.
Biointerphases 10 (2), 021007 (2015). |
209.
|
Benck
U., Schnuelle P., Habicht A., Renders L., Zeier M., Heller K., Pisarski
P., Banas B., Kramer B.K., Jung M., Lopau K., Olbricht C.J., Weihprecht
H., Schenker P., De Fijter H.W., Yard B., Schmitt W.H.
Effects
of dopamine donor pretreatment on graft function after kidney
transplantation: five-year follow-up of a randomized controlled trial.
Transplant
International 28 (S2), 3 (2015).
|
208.
|
Bialobrzecka
M., Kühn P., Berger L., Wunsch A., Viebahn R.
Contrast-enhanced
ultrasonography of the pankreas graft.
Transplant
International 28 (S2), 18 (2015). |
207.
|
Carolus
A. E., Schenker P., Dombert T., Fontana J., Viebahn R., Schmieder K.,
Brenke C.
Sonographic
examination of the median nerve in dialysis patients and after renal
transplantation.
Brain
and Behavior5 (12) e00406 (2015).
|
206.
|
Dragun D.,
Sommerer C., Suwelack B., Hauser I.A., Schenker P., Baumer D., Nashan
B., Thaiss F.
Design
and rationale of athena study: a 12-month study evaluating everolimus
versus standard regimen in de novo renal transplant recipients-baseline
data.
Transplant
International 28 (S2), 24 (2015). |
205.
|
Roedel C., Graeven U., Fietkau R., et al. (German Rectal
Cancer Study Group).
Oxaliplatin
added to fluorouracil-based preoperative chemoradiotherapy and
postoperative chemotherapy of locally advanced rectal cancer (the
German CAO/ARO/AIO-04 study): final results of the multicentre,
open-label, randomised, phase 3 trial.
Lancet Oncology
16 (8),
979-989 (2015). |
204.
|
Schenker
P., Arns W., Rath T., Rump L.C., Baeumer D., Budde K.
Evaluation
of pharmacokinetic and clinical outcomes with Tacrolimus hexal (r)
versus Prograf (r) based regimen in de novo renal transplant patients:
results from a randomised, multicentre study (SparTacus).
Transplant
International 28 (S4), 820 (2015). |
203.
|
Schenker
P., Klein T., Grzella S., Kykalos S., Viebahn R.
Once-daily
modified-release tacrolimus in de novo simultaneous pancreas-kidney
transplant patients: a five-year prospective study.
Transplant
International 28 (S2), 30 (2015). |
202.
|
Sommerer
C., Suwelack B., Dragun D., Hauser I., Schenker P., Baumer D., Nashan
B., Thaiss F.
12-Month
Athena Study: Everolimus vs. Standard Regimen in De Novo Renal
Transplant Recipients.
American
Journal of Transplantation 15 (3),
(2015). |
201.
|
Sommerer
C., Suwelack B., Dragun D., Hauser I., Schenker P., Baumer D., Nashan B.,
Thaiss F.
12-Month
Athena Study: Everolimus vs. Standard Regimen in De Novo Renal
Transplant Recipients.
Transplant
International 28 (S4), 450 (2015).
|
200.
|
Wunsch
A., Bialobrzecka M., Jazra M., Kühn P., Schenker P., Viebahn R.
Is it
possible to predict renal transplant function by an estimation of the
gfr using the available donor data?
Transplant
International 28 (S2), 56 (2015).
|
199.
|
Berger
L., Bialobrzecka M., Schenker P., Viebahn R., Wunsch A.
Patient
and graft survival after pancreas retransplantation: a retrospective
analysis of the outcome in a single center.
Transplant
International 27 (S3), 31 (2014). |
198.
|
Bialobrzecka
M., Wunsch A., Berger L., Kühn P., Viebahn R.
Different
ways of protecting a kidney transplant during aortic or aortoiliac
reconstruction.
Transplant
International 27 (S3), 29 (2014). |
197.
|
Grzella S., Viebahn R., Schenker P.
Comparison
of histidine-tryptophan-ketoglutarate (HTK) solution and University of
Wisconsin (UW) solution in pancreas transplantation.
Transplant
International 27 (S3), 18 (2014).
|
196.
|
Jazra
M., Kuhn P., Schenker P., Wunsch A., Kykalos S., Viebahn R.
Two
cases of enterohemorrhagic escherichia coli (EHEC) detection in
solid-organ transplant recipients.
Transplant
International 27 (S3), 29 (2014).
|
195.
|
Kühn
P., Bolesta K., Rifaie N., Schenker P., Wunsch A., Viebahn R.
Long
term quality of life after combined pancreas-kidney transplantation.
Transplant
International 27 (S3), 35 (2014).
|
194.
|
Kykalos
S., Jazra M., Kuhn P., Wunsch A., Viebahn R.
Results
of living donor kidney transplantations from donors aged more than 65
years.
Transplant
International 27 (S3), 36 (2014).
|
193.
|
Nardi
F.D., Kuehn P., Wunsch A., Bicalho M.D., Heinemann F.M., Horn P.A.,
Viebahn R., Rebmann V.
HLA-E
polymorphisms impacts on human cytomegalovirus reinfection in
simultaneous kidney-pancreas transplantation.
Tissue Antigens
84 (1),
72-73 (2014). |
192.
|
Pillokeit
N., Jazra M., Schenker P., Wunsch A., Viebahn R.
Relevance
of ureteral complications in kidney transplant patients.
Transplant
International 27 (S3), 29 (2014). |
191.
|
Schenker
P., Klein T., Jazra M., Kuhn P., Grzella S., Viebahn R.
Renal
transplantation using donors older than 80 years: a single-center
experience.
Transplant
International 27 (S3), 30 (2014).
|
190.
|
Teodoridis
A., Schenker P., Wunsch A., Viebahn R.
Long-term
mortality in patients after simultaneous
pancreas-kidney-transplantation.
Transplant
International 27 (S3), 38 (2014). |
189.
|
Touloumtzidis
A., Sostmann B., Hilgers N., Renter M.A., Kühn P., Goretzki P.E.,
Lammers B.J.
Functional
long-term results after rectal cancer surgery--technique of the
athermal mesorectal excision.
International
Journal of Colorectal Disease 29 (3),
285-92 (2014). |
188.
|
Viebahn
R.
Gesundheitsforschung
– Versorgungsforschung zur Verbesserung der Qualität. [Health care
research for improving quality].
Zentralblatt
für Chirurgie 139 (2),
139-142 (2014). |
187.
|
Viebahn
R., Kuhn P., Wunsch A., Schenker P.
Delisting
and "inactive status": survey on ethical aspects of managing a waiting
list in times of decreasing organ donation.
Transplant
International 27 (S3), 17 (2014).
|
186.
|
Walter
M., Jazra M., Kykalos S., Kuehn P., Michalski S., Klein T., Wunsch A.,
Viebahn R., Schenker P.
125
cases of duodenoduodenostomy in pancreas transplantation: a
single-centre experience of an alternative enteric drainage.
Transplant
International 27 (8), 805-815 (2014). |
185.
|
Witzke
O., Opgenoorth M., Sommerer C., Suwelack B., Lehner F., Dragun D.,
Hauser I.A., Schenker P., Baumer D., Nashan B., Thaiss F.
12-month
ATHENA study: everolimus vs. standard regimen in de novo renal
transplant recipients.
Transplant
International 27 (S3), 51 (2014).
|
184.
|
Floros
G., Moder A., Kykalos S., Jazra M., Wunsch A., Viebahn R.
Pneumonia
in kidney and kidney-pancreas transplant patients.
Transplant
International 26 (S1), 42 (2013). |
183.
|
Goetting
S., Kuehn P., Schenker P., Wunsch A., Klein T., Muermann K., Viebahn
R.
Are
marginal donorcriteria a riskfactor for graft thrombosis in
pancreas-transplantation?
Transplant
International 26 (S1), 38 (2013).
|
182.
|
Jazra
M., Klein T., Schenker P., Wunsch A., Kykalos S., Viebahn R.
Severe
anemia due to parvo virus b19 infection in a patient after living donor
kidney transplantation - successful treatment using high-dose
immunoglobulins.
Transplant
International 26 (S1), 44 (2013).
|
181.
|
Kadmon
M., Ganschow P., Gillen S., Hofmann H.S., Braune N., Johannink J., Kühn
P., Buhr H.J., Berberat P.O.
Der
kompetente Chirurg. Brückenschlag zwischen der Ausbildung im
Praktischen Jahr und der chirurgischen Weiterbildung. [The competent
surgeon. Bridging the gap between undergraduate final year and
postgraduate surgery training].
Der Chirurg 84 (10), 859-868 (2013). |
180.
|
Kuehn
P., da Silva Nardi F., Wunsch A., Heinemann F.M., Horn P.A., Viebahn
R., Rebmann V.
MICB -
a ligand for the activating natural killer receptor NKG2D-is a marker
for the prediction of graft rejection after combined kidney-pancreas
transplantation.
Transplant
International 26 (S1), 14 (2013). |
179.
|
Kuehn
P., Goetting S., Muermann K., Schenker P., Wunsch A., Viebahn R.
Single
center study: outcome after 428 combined
pancreas-kidney-transplantations.
Transplant
International 26 (S1), 14 (2013). |
178.
|
Kuehn
P., Goetting S., Schenker P., Wunsch A., Viebahn R.
Developement
of donor criteria of combined pankreas-kidney-donation within the last
10 years.
Transplant
International 26 (S1), 37 (2013). |
177.
|
Kykalos
S., Wunsch A., Klein T., Mitchell A., Viebahn R.
Successful
pancreas/kidney re-transplantation by a patient with very high panel
reactive antibodies. our desensitization protocol.
Transplant
International 26 (S1), 31 (2013). |
176.
|
Moder A., Wunsch A., Viebahn R.
Autotransplantation
for the treatment of severe renal artery stenosis and aneurysm in a
solitary kidney
after repeated coiling: a case report.
Transplant
International 26 (S1), 47 (2013).
|
175.
|
Porwol
D., Wunsch A., Kuehn P., Schenker P., Viebahn R.
Demographic
challenges of simultaneous pancreas-kidney transplantation (st) 2005 to
2012: a single-center experience.
Transplant
International 26 (S1), 47-48 (2013). |
174.
|
Proneth A., Schnitzbauer A.A., Zeman F., Foerster J.R.,
Holub I., Arbogast H., Bechstein W.O., Becker T., Dietz C., Guba M.,
Heise M., Jonas S., Kersting S., Klempnauer J., Manekeller S., Müller
V., Nadalin S., Nashan B., Pascher A., Rauchfuss F., Ströhlein M.A.,
Schemmer P., Schenker P., Thorban S., Vogel T., Rahmel A.O., Viebahn
R., Banas B., Geissler E.K., Schlitt H.J., Farkas S.A.
Extended
pancreas donor program - the EXPAND study rationale and study protocol.
Transplantation
Research 2 (1), 12 (2013).
|
173.
|
Rueb
J., Kühn P., Viebahn R., Wunsch A.
Predicting
quality of deceased donor kidneys: the harvesting surgeon as a
prognostic factor?
Transplantation
Proceedings 45 (4), 1360-1362
(2013). |
172.
|
Schenker
P., Viebahn R.
Perspektiven
der kombinierten Pankreas-Nieren-Transplantation.
Deutsche
Medizinische Wochenschrift 18, 958-963
(2013). |
171.
|
Schenker
P., Walter M., Jazra M., Kuehn P., Kykalos S., Wunsch A., Viebahn R.
125 cases of
duodenoduodenostomy in pancreas transplantation: a single-center
experience of an alternative enteric drainage.
Transplant
International 26 (S1), 14 (2013). |
170.
|
Teodoridis
A., Schenker P., Wunsch A., Viebahn R.
Metabolic
follow-up four years after simultaneous pancreas-kidney transplantation
with portal venous versus systemic venous drainage.
Transplant
International 26 (S1), 48 (2013).
|
169.
|
Viebahn
R., Greif-Higer G.
Neuer
Transplantationskodex: Verantwortung gegenüber Spendern und Empfängern.
Deutsches
Ärzteblatt 110 (51-52), A-2465 (2013).
Link zum Artikel
| Artikel als PDF-Datei |
168.
|
Viebahn
R.
The
german transplant scandal: reflections of an insider.
Transplant
International 26 (S1), 10 (2013). |
167.
|
Viebahn R., Wunsch A., Michalski S., Kühn P., Porwol D.,
Goetting S., Schenker P.
OLD-TO
OLD – Allocation in pancreas transplantation –impact of different
cutoff ages.
Transplant
International 26 (S1), 5
(2013). |
166.
|
Walter
M., Klein T., Jazra M., Kykalos S., Kühn P., Wunsch A., Viebahn R.,
Schenker P.
125
Cases of Duodenoduodenostomy in Pancreas Transplantation: A
Single-Center Experience of an Alternative Enteric Drainage.
American
Journal of Transplantation 13 (5), 442
(2013). |
165.
|
Walter
M., Jazra M., Kuehn P., Wunsch A., Viebahn R., Schenker P.
125 cases of
duodenoduodenostomy in pancreas transplantation: a single-center
experience of an alternative enteric drainage.
Transplant
International 26 (S2), 6
(2013).
|
164.
|
Quang
M. N., Krüger B., Wenning M., Krüger C. D., Tokmak F., Kisters K.,
Wunsch A., Schenker P., Viebahn R., Krämer B.K.
Autotransplantation
for the treatment of severe renal artery stenosis in a solitary kidney
after repeated percutaneous transluminal angioplasty: a case report.
Clinical
nephrology 78 (5), 418-422 (2012). |
163.
|
Roedel C., Liersch T., Becker H. et al., German Rectal
Cancer Study Group (Viebahn R., Member).
Preoperative
chemoradiotherapy and postoperative chemotherapy with fluorouracil and
oxaliplatin versus fluorouracil alone in locally advanced rectal
cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3
trial.
Lancet
Oncology 13 (7), 679-687 (2012). |
162.
|
Rueb J., Kühn P., Viebahn R., Wunsch A.
Predicting
Quality of Deceased Donor Kidneys: The Explant Surgeon as a Prognostic
Factor?
Transplantation 94 (10S), 923 (2012). |
161.
|
Schenker P., Ziarna S., Jazra M., Grzella S., Hempel C.,
Teodoridis A., Viebahn R.
Thymoglobulin
Induction and Calcineurin Inhibitor Delay in the Eurotransplant Senior
Kidney Program - A 10-Year Single Center Experience.
Transplantation
94 (10S),
976-977 (2012). |
160.
|
Wunsch
A., Kühn P., Schenker P., Viebahn R.
Massive
Bleeding as a Late Complication of Combined Pancreas-Kidney Transplantation.
Transplantation
94 (10S),
698 (2012). |
159.
|
Grzella
S., Langsdorff C. von, Stricker I., Pox C., Wunsch A., Viebahn R.
Heterotopes
Pankreasgewebe – vom Zufallsbefund über Beschwerden zur Therapie und
Diagnose.
Zentralblatt
für Chirurgie 136 (5), 537-537 (2011). |
158.
|
Holstein A., Wunsch A.
Isolierte
Pankreastransplantation bei nicht-urämischer Typ-1-Diabetikerin mit
schwersten Hypoglykämie-Wahrnehmungsstörungen [Pancreas Transplantation
Alone in a Nonuremic Woman with Type1 Diabetes mellitus and
TotalUnawareness of
Hypoglycemia].
Diabetologie
und Stoffwechsel 6 (5),
329-330 (2011). |
157.
|
Jazra
M., Schenker P., Hempel C., Wunsch A., Altenhenne C., Anders A.,
Viebahn R.
Ulcus
cruris due to pseudallescheria boydii infection after renal
transplantation - a rare differential diagnosis in a common lesion.
Transplant
International 24 (S2), 230 (2011).
|
156.
|
Jazra
M., Schenker P., Wunsch A., Grzella S., Viebahn R.
Kombinierte
Pankreas-/Nierentransplantation – präemptiv versus nicht-präemptiv.
Zentralblatt
für Chirurgie 136 (5),
517-517 (2011). |
155.
|
Kampfenkel
T., Tischoff I., Bonhag H., Eckardt M., Schmiegel W., Tannapfel A.,
Reinacher-Schick A., Viebahn R.
Chemotherapy-associated
steatohepatitis in patients with colorectal cancer and surgery on
hepatic metastasis: clinical validation of a histopathological scoring
system and preoperative risk assessment.
Zeitschrift für
Gastroenterologie 49 (10),
1407-1411 (2011). |
154.
|
Kühn
P., Wunsch A., Viebahn R.
Spinale Lipomatose
als seltene Ursache neurologischer Veränderungen bei transplantierten
Patienten.
Zentralblatt
für Chirurgie 136 (5),
534-534 (2011). |
153.
|
Pfannkuchen
B., Langsdorff C. von, Allekseyev A., Pox C., Wunsch A., Viebahn R.
Aortoduodenale
Fistel – seltene Komplikation einer Aortenprothese.
Zentralblatt
für Chirurgie 136 (5),
533-533 (2011). |
152.
|
Schenker
P., Hempel C., Jazra M., Wunsch A., Viebahn R.
Modified
release tacrolimus in de novo immunosuppression after simultaneous
pancreas kidney transplantation.
Transplant
International 24 (S3), 45 (2011).
|
151.
|
Schenker
P., Oezturk A., Vonend O., Krüger B., Jazra M., Krämer B.K., Viebahn R.
Thymoglobulin
induction in living-donor renal transplantation.
Transplant
International 24 (S2), 300-301 (2011). |
150.
|
Schenker
P., Özturk A., Vonend O., Krüger B., Jazra M., Wunsch A., Krämer B.K.,
Viebahn R.
Single-dose
thymoglobulin induction in living-donor renal transplantation.
Annals
of Transplantation 16 (2), 50-58 (2011). |
149.
|
Schenker
P., Vonend O., Krüger B., Klein T., Michalski S., Wunsch A., Krämer
B.K., Viebahn R.
Long-term
results of pancreas transplantation in patients older than 50 years.
Transplant
International 24 (2), 136-142 (2011). |
148.
|
Shah S.,
Viebahn R.
Konzepte der
individuellen Chirurgie bei der Cholezystolithiasis – Eine Analyse der
derzeit möglichen Techniken.
Zentralblatt
für Chirurgie 136 (5),
503-503 (2011). |
147.
|
Swol
J., Viebahn R., Schildhauer T.A.
Intensivmedizinische
Versorgung nach Abdominaltrauma. [Surgical intensive care
after
abdominal injuries].
Viszeralmedizin
27 (1),
41-49 (2011). |
146.
|
Teodoridis
A., Schenker P., Wunsch A., Viebahn R.
Chirurgische
Komplikationen nach kombinierter Pankreas-Nieren-Transplantation mit
portal-venöser versus systemisch-venöser Drainagetechnik.
Zentralblatt
für Chirurgie 136 (5),
517-517 (2011). |
145.
|
Traska T.,
Wunsch A., Claeys L.
Morbiditätsanalyse
und Therapie inguinaler Lymphfisteln in der Gefäßchirurgie.
Zentralblatt
für Chirurgie 136 (5),
516-516 (2011). |
144.
|
Viebahn R.
Zum Geleit: 178.
Jahrestagung der Vereinigung Niederrheinisch-Westfälischer Chirurgen am
20. und 21.10.2011 in Bochum.
Zentralblatt
für Chirurgie 136 (5),
502 (2011). |
143.
|
Frahnert
M., Quang M., Wunsch A., Wenning M., Wolter S., Viebahn R., Wenze U.
Immunadsorption
with protein a and oral galactose therapy in recurrent focal segmental
glomerulosclerosis after renal transplantation.
Transplant
International 23 (S2), 56 (2010).
|
142.
|
Jazra
M., Schenker P., Wunsch A., Viebahn R.
Kidney
transplantation in previous heart transplantat recipients.
Transplant
International 23 (S2), 57 (2010).
|
141.
|
Kampfenkel
T., Tannapfel A., Tischoff I., Viebahn R., Schmiegel W.,
Reinacher-Schick A.
Risk
factors for the development of chemotherapy-associated steatohepatitis
measured in correlation with the 'CASH-score' in Liver lesions in
metastatic colorectal cancer.
Onkologie
33,
74 (2010). |
140.
|
Krämer
B.K., Charpentier B., Bäckman L., Silva H.T., Mondragon-Ramirez G.,
Cassuto-Viguier E., Mourad G., Sola R., Rigotti P., Mirete J.O.,
Tacrolimus Prolonged Release Renal Study Group
Tacrolimus
once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal
transplantation: a randomized phase III study.
American Journal of
Transplantation 10 (12),
2632-2643 (2010). |
139.
|
Öztürk A.,
Klein T., Jazra M., Wunsch A., Michalski S., Viebahn R., Schenker P.
Thymoglobulin
induction in living donor kidney transplant recipients.
Transplant
International 23 (S2), 57 (2010). |
138.
|
Rebmann V.,
Möllenbeck P., Bartsch D., Heinemann F.M., Wunsch A., Golda T., Viebahn
R.
Soluble
HLA-G as an indicator for graft rejection in kidney and kidney/pancreas
transplantation superior to soluble CD30 levels.
Transplant
International 23 (S2), 64 (2010). |
137.
|
Rebmann
V., Möllenbeck P., Bartsch D., Wunsch A., Golda T., Grosse-Wilde H.,
Viebahn R., Horn P.A.
The
clinical value of soluble HLA-G and soluble CD30 levels in kidney and
kidney/pancreas transplantation.
Tissue Antigens
75 (5),
583 (2010). |
136.
|
Schenker
P., Klein T., Wunsch A., Teodoridis A., Öztürk A., Jazra M., Viebahn R.
Conversion
from a calcineurin inhibitor to everolimus after simultaneous
pancreas-kidney transplantation (spk).
Transplant
International 23 (S2), 38 (2010).
|
135.
|
Schenker P.,
Vonend O., Ertas N., Wunsch A., Viebahn R.
Preprocurement
pancreas allocation suitability score does not correlate with long-term
pancreas graft survival.
Transplantation
Proceedings 42, 178-180 (2010). |
134.
|
Teodoridis
A., Jazra M., Wunsch A., Heuser L., Viebahn R., Schenker P.
Percutaneous
transluminal stent angioplasty as treatment of pancreas transplant
artery stenosis.
Transplant
International 23 (S2), 46 (2010). |
133.
|
Gumprich M.,
Schenker P., Vonend O., Wunsch A., Viebahn R.
Rosiglitazon bei
Hyperglykämie nach kombinierter Pankreas-/Nierentransplantation.
Diabetologie
und Stoffwechsel 4,
P303 (2009). |
132.
|
Krüger B.,
Walberer A., Farkas S., Tokmak F., Obed A., Schenker P., Henning B.,
Schlitt H.J., Krämer B.K., Banas B.
The
Impact of "High-Producer" Interleukin-6 Haplotypes on Cardiovascular
Morbidity and Mortality in a Kidney Transplant Population.
Transplantation
Proceedings 41, 2539-2543 (2009).
|
131.
|
Ludwig
S., Mannherz H.G., Schmitt S., Schäffer M., Zentgraf H., Napirei M.
Murine
serum deoxyribonuclease 1 (Dnase1) activity partly originates from the
liver.
The International
Journal of Biochemistry & Cell Biology 41 (5), 1079-1093 (2009).
|
130.
|
Rebmann V.,
Bartsch D., Wunsch A., Möllenbeck P., Golda T., Viebahn R.,
Grosse-Wilde H.
Soluble
total human leukocyte antigen class I and human leukocyte antigen-G
molecules in kidney and kidney/pancreas transplantation.
Human Immunology
70 (12),
995-999 (2009). |
129.
|
Schenker
P., Flecken M., Vonend O., Wunsch A., Traska T., Viebahn R.
En
bloc retroperitoneal pancreas-kidney transplantation with
duodenoduodenostomy using pediatric organs.
Transplantation
Proceedings 41 (6), 2643-2645 (2009).
|
128.
|
Schenker P.,
Vonend O., Krüger, B., Krämer B.K., Viebahn R.
Modified
release tacrolimus in de novo immunosuppression after simultaneous
pancreas kidney transplantation - a first single-center experience.
Transplant
International 22 (S2), 331-332
(2009). |
127.
|
Schenker
P., Klein T., Krüger B., Claas S., Wunsch A., Traska T., Krämer B.K.,
Viebahn R.
Modified
release tacrolimus in de novo immunosuppression after simultaneous
pancreas-kidney transplantation-a first single-center experience.
Transplantation
Proceedings 41 (6), 2573-2575 (2009). |
126.
|
Schenker P.,
Viebahn R.
Pankreas- und
Inseltransplantation - Stellenwert in der Therapie des Diabetes
mellitus.
Der Chirurg 80
(5), 422-429 (2009). |
125.
|
Schenker P.,
Vonend O., Ertas N., Wunsch A., Schaeffer M., Rump L.C., Viebahn R.
Incidence
of pancreas graft thrombosis using low-molecular-weight heparin.
Clinical
Transplantation 23 (3), 407-414
(2009). |
124.
|
Shah
S., Scholz A., Reber H., Schreckenberger M., Viebahn R., Lang H.,
Korenkov M.
Laparoscopic
radioisotope-guided sentinel lymph node mapping and excision of the
rectum--an experimental study.
Langenbeck's
Archives of Surgery 394 (3), 483-487
(2009). |
123.
|
Suermann
A., Vonend O., Schenker P., Viebahn R., Rump L.C., Weiner S.M.
Plasma
complement 3d levels in the early phase after pancreas transplantation.
Annals
of Transplantation 14 (3), 29-35 (2009). |
122.
|
Viebahn R.
17th
annual meeting of the German transplantation society preface.
Transplantation
Proceedings 41 (6), 2501-2501 (2009). |
121.
|
Viebahn
R., Klein H., Kraemer B., Schenker P.
Is
pancreas transplantation getting old? Single-center experience in an
aging society.
Clinical
Transplants, 165-169 (2009).
|
120.
|
Brett D., Seybold D., Michalski S., Muhr G.
Acute
traumatic abdominal wall hernia after blunt abdominal trauma.
Der
Unfallchirurg 111, 361-364 (2008). |
119.
|
Malaise J., De Roover A., Squifflet J.P., Land W.,
Neuhaus P., Pratschke J., Kahl A., Pascher A., Boas-Knoop S., Arbogast
H., Hoffmann J., Illner W.D., Seissler, Schlamp, Viebahn. R., Wunsch.
A., Hajt S., Klar E., Scharek W., Hopt, Pisarski P., Drognitz O.,
Thurow C., Dette K., Bechstein WO., Woeste G., Klempnauer J., Becker
T., Lück, Neipp., Königsrainer A., Steurer W., Margreiter R., Mark.,
Bonatti., Saudek F., Boucek P., Adamec M., Havrdova T., Koznarova R.,
Vanrenterghem Y., Pirenne J., Maes B., Kuypers D., Coosemans W.,
Evenepoel P., van Ophem D., Marcelis V., van Vlem., Peeters., de
Hemptinne., de Roose., Fernandez-Cruz L., Ricart MJ., Nakache R., Morel
P., Berney T., Demuylder S.; Euro SPK Study Group.
Immunosuppression
in pancreas transplantation: the Euro SPK trials and beyond.
Acta Chirurgica
Belgica 108 (6),
673-678 (2008). |
118.
|
Schenker
P., Wunsch A., Ertas N., Schäffer M., Rump L. C., Viebahn R., Vonend O.
Long-term
results after simultaneous pancreas-kidney transplantation using donors
aged 45 years or older.
Transplantation
Proceedings 40, 923-926 (2008).
|
117.
|
Ertas
N., Wunsch A., Kraus M., Gatermann S., Viebahn R., Schäffer M.
Letal
pneumonia by streptococcus pyogenes 4 weeks after simultaneous
pancreas-kidney-transplantation - A case report.
Inflammation
Research 56, S312 (2007). |
116.
|
Ertas
N., Wunsch A., Schenker P., Vonend O., Kraus M., Gatermann S., Viebahn
R., Schäffer M.
Letal
pneumonia by streptococcus pyogenes one year after
pancreas-kidney-transplantation.
Proceedings
of the 7th World Congress on Trauma, Shock, Inflammation and Sepsis, 59-62 (2007). |
115.
|
Hugo
C., Frei U., Margreiter R., Peeters P., Ok E., Viebahn R., Pietruck F.,
Ekberg H.
Elderly
kidney transplant recipients are a high-risk group for death,
infections and post-transplant diabetes: Evidence from the symphony
study.
Transplant
International 20 (S2), 84 (2007).
|
114.
|
Hugo
C., Frei U., Margreiter R., Peeters P., Ok E., Viebahn R., Pietruck F.,
Ekberg H.
Elderly
kidney transplant recipients are a high-risk group for death,
infections and PTx diabetes: Evidence from the symphony study.
American Journal of
Transplantation 7, 186
(2007). |
113.
|
Malaise
J., Pratschke J., Saudek F., Margreiter R., Arbogast H., Fernandez-Cruz
L., Pisarski P., Viebahn R., Peeters P.
Sirolimus
versus mycophenolate mofetil in tacrolimus based primary simultaneous
pancreas-kidney (SPK) transplantation: 1 yr results of multicentre
trial.
Xenotransplantation
14 (5), 380
(2007).
|
| 112. |
Pratschke
J., Malaise J., Saudek F., Margreiter R., Arbogast H., Fernandez-Cruz
L., Pisarski P., Viebahn R., Peeters P., Nakache R., Berney T.,
Vanrenterghem Y., Bechstein W.
Sirolimus
versus mycophenolate mofetil in tacrolimus based primary simultaneous
pancreas-kidney (SPK) transplantation: 1 year results of a multicentre
trial.
Transplant
International 20 (S2),
78-79 (2007). |
| 111. |
Schäffer
M., Bartmann V., Wunsch A., Traska T., Schenker P., Michalski S.,
Viebahn R.
Kombinierte
Nieren-Pankreas-Transplantation. Einfluss des Spender- und
Empfängergeschlechts. [Simultaneous pancreas-kidney transplantation. Influence
of donor and recipient gender].
Der Chirurg
78,
928-935 (2007). |
| 110. |
Schäffer
M., Bongartz M., Fischer S., Proksch B., Viebahn R.
Nitric
oxide restores impaired healing in normoglycaemic diabetic rats.
Journal
of wound care 16, 311-316 (2007).
|
| 109. |
Schäffer
M., Bongartz M., Hoffmann W., Viebahn R.
MHC-class-II-deficiency
impairs wound healing.
Journal
of Surgical Research 138, 100-105 (2007). |
| 108. |
Schäffer M., Schier R., Michalski S., Napirei M.,
Schenker P., Viebahn R.
Rapamycin
impairs wound healing: Possible role of VEGF and nitric oxide.
Inflammation
Research 56, S201 (2007).
|
| 107. |
Schäffer
M., Schier R., Michalski S., Napirei M., Traska T., Schenker P.,
Viebahn R.
Possible
role of VEGF and nitric oxide in rapamycin-impaired wound healing.
Proceedings
of the 7th World Congress on Trauma, Shock, Inflammation and Sepsis, 137-139 (2007). |
| 106. |
Schäffer
M., Schier R., Napirei M., Michalski S., Traska T., Viebahn R.
Sirolimus impairs
wound healing.
Langenbecks
Archiv für Chirurgie 392,
297-303 (2007). |
| 105. |
Schäffer
M., Wunsch A., Michalski S., Traska T., Schenker P., Viebahn R.
Morbidity
and mortality of kidney and pancreas transplantation: analysis of 810
transplantations at one center.
Deutsche
Medizinische Wochenschrift 132,
2318-2322 (2007). |
| 104. |
Schenk
M., Ladurner R., Steurer W., Knubben K., Thiel C., Viebahn R.,
Konigsrainer A.
Regenerative
signals of the liver after transplantation.
Transplant
International 20 (S1), 6 (2007).
|
| 103. |
Schenker
P., Vonend O., Ertas N., Wunsch A., Rump L.C., Viebahn R.
Long
term results after simultaneous pancreas-kidney transplantation using
donors aged 45 years or older.
Transplant
International 20 (S2), 308 (2007). |
| 102. |
Schenker
P., Weiner S., Vonend O., Rump L., Viebahn R., Schäffer M.
Pneumonitis
associated with sirolimus: Clinical characteristics, risk factors and
outcome.
Inflammation
Research 56, S140-S141 (2007).
|
| 101. |
Schenker
P., Weiner S.M., Vonend O., Flecken M., Rump L.C., Viebahn R., Schäffer
M.
Pneumonitis
associated with sirolimus: Clinical characteristics, risk factors and
outcome.
Proceedings
of the 7th World Congress on Trauma, Shock, Inflammation and Sepsis, 141-144 (2007). |
| 100. |
Weiner
S.M., Sellin L., Vonend O., Schenker P., Buchner N.J., Flecken M.,
Viebahn R., Rump L.C.
Pneumonitis
associated with sirolimus: clinical characteristics, risk factors and
outcome- a single-centre experience and review of the literature.
Nephrology
Dialysis Transplantation 22,
3631-3637 (2007). |
| 99. |
Gartner
V., Eigentler T.K., Viebahn R.
Plasma
cell-rich rejection processes in renal transplantation: Morphology and
prognostic relevance.
Transplantation
81,
986-991 (2006). |
| 98. |
Radny
P., Eigentler T.K., Soennichsen K., Overkamp D., Raab H.R., Viebahn
R., Mueller-Horvart C., Sotlar K., Rassner G.
Metastatic
glucagonoma: Treatment with liver transplantation.
Journal
of the American Academy of Dermatology 54, 344-347 (2006).
|
| 97. |
Schaeffer
M., Schier R., Michalski S., Napirei M., Viebahn R.
Rapamune
impairs wound healing.
Proceedings
of the XLI Congress of the European Society for Surgical Research,
75-77 (2006). |
| 96. |
Schäffer
M., Bongartz M., Hoffmann W., Viebahn R.
Regulation
of nitric oxide synthesis in wounds by IFN-gamma depends on TNF-alpha.
Journal
of Investigative Surgery 19, 371-379 (2006).
|
| 95. |
Bockmann
R.A., Schulz T., Stein H., Mielke E., Dengler K., Wolff K.D., Nolte
D.
Bilateral
synchronous submandibular lumps in a patient with gastric carcinoma.
Journal
of Oral Pathology & Medicine 34, 127-128 (2005).
|
| 94. |
Kapischke
M., Bley K., Tepell J., Schulz T.
Open
versus laparoscopic operation for perforated appendicitis - A
comparative study.
Zentralblatt
für Chirurgie 130,
137-140 (2005). |
| 93. |
Kapischke
M., Prinz K., Tepel J., Tensfeldt J., Schulz T.
Comparative
investigation of alloplastic materials for hernia repair with improved
methodology.
Surgical
Endoscopy and Other Interventional Techniques 19, 1260-1265 (2005). |
| 92. |
Kapischke
M., Prinz K., Tepel J., Tensfeldt J., Schulz T.
Precoating
of alloplastic materials with living human fibroblasts - A feasibility
study.
Surgical
Endoscopy and Other Interventional Techniques 19, 791-797 (2005). |
| 91. |
Kapischke
M., Tepel J., Pai M., Schulz T.
Sigmoid
perforation by compressed carbon dioxide.
Scandinavian
Journal of Gastroenterology 40,
356-359 (2005). |
| 90. |
Schäffer
M., Fuchs N., Volker J., Schulz T., Kapischke M., Viebahn R.
Differential
effect of tacrolimus on dermal and intestinal wound healing.
Journal
of Investigative Surgery 18, 71-79 (2005).
|
| 89. |
Schulz
T., Flecken M., Kapischke M., Büsing M.
Single-shot
antithymocyte globuline and daclizumab induction in simultaneous
pancreas and kidney transplant recipient: Three-year results.
Transplantation
Proceedings 37, 1818-1820 (2005).
|
| 88. |
Schulz
T., Flecken M., Schenker P., Schäffer M., Viebahn R., Kapischke M.
Pancreas
removal by external teams.
Der
Chirurg 76, 581-586 (2005). |
87.
|
Schulz
T., Papapostolou G., Schenker P., Kapischke M.
Single-shot
antithymocyte globulin (ATG) induction for pancreas/kidney
transplantation: ATG-Fresenius versus Thymoglobulin.
Transplantation
Proceedings 37 (2),
1301-1304 (2005). |
| 86. |
Schulz
T., Kapischke M., Büsing M.
Neoquadruple
induction with antithymocyte globulin/azathioprine/
cyclosporine/prednisolone in simultaneous pancreas and kidney
transplant recipients: 8.5-year results.
Transplantation
Proceedings 37, 1815-1817 (2005). |
| 85. |
Schulz
T., Schenker P., Flecken M., Kapischke M.
Donors
with a maximum body weight of 50 kg for simultaneous pancreas-kidney
transplantation.
Transplantation
Proceedings 37, 1268-1270 (2005). |
| 84. |
Schulz
T., Schenker P., Flecken M., Schäffer M., Viebahn R., Kapischke M.
Combined
pancreas kidney transplantation after isolated kidney transplantation.
Zentralblatt
für Chirurgie 130, 132-136 (2005). |
| 83. |
Braun
N., Wernet D., Schnaidt M., Bevan D.J., Viebahn R., Risler T.
Successful
treatment of accelerated vascular rejection in a highly immunised renal
transplant recipient with immunoadsorption and 15-deoxyspergualin.
Transplant
International 17 (7), 384-386 (2004). |
| 82. |
Kapischke
M., Tepel J., Bley K.
Laparoscopic
appendicectomy is associated with a lower complication rate even during
the introductory phase.
Langenbecks
Archiv für Chirurgie 389, 517-523 (2004).
|
| 81. |
Schäffer M.
Inflammatory
mediators in radiation-impaired wound healing.
Shock 21, 137 (2004). |
| 80. |
Schäffer M.,
Tantry U., Barbul A.
Wound
fluid inhibits wound fibroblast nitric oxide synthesis.
The
Journal of surgical research 122 (1), 43-48 (2004). |
| 79. |
Taheri
A.S., Golda T.O., Reiser M., Michalski S., Schäffer M., Viebahn R.
Rezidivierende
gastrointestinale Blutung aus einem Meckel'schen Divertikel:
Stellenwert der Chirurgie bei Versagen der erweiterten Diagnostik
mittels Kapselendoskopie.
Endoskopie
heute 17, V33 (2004). |
| 78. |
Braun
N., Dette S., Viebahn R.
Impairment
of renal function following liver transplantation.
Transplantation
Proceedings 35, 1458-1460 (2003).
|
| 77. |
Fillon
S., Klingel K., Warntges S., Sauter M., Gabrysch S., Pestel S., Tanneur
V., Waldegger S., Zipfel A., Viebahn R., Broer S., Kandolf R., Lang F.
Expression
of the serine/threonine kinase hSGK1 in chronic viral hepatitis.
Cellular
Physiology and Biochemistry 12, 47-54 (2002).
|
| 76. |
Linti
C., Zipfel A., Schenk M., Dauner M., Doser M., Viebahn R., Becker H.D., Planck H.
Cultivation
of porcine hepatocytes in polyurethane nonwovens as part of a biohybrid
liver support system.
International
Journal of Artificial Organs 25, 994-1000 (2002).
|
| 75. |
Manz
M.G., Berger C., Horny H.P., Beck R., Brugger W., Viebahn R., Kanz
L., Knecht H.
Sustained
remission of an extensive monoclonal, Epstein-Barr virus-associated
diffuse large B cell lymphoma in a kidney-pancreas transplant
recipient.
Transplantation
73,
995-997 (2002). |
| 74. |
Axel
D.I., Frigge A., Dittmann J., Runge H., Spyridopoulos I., Riessen R.,
Viebahn R., Karsch K.R.
All-trans
retinoic acid regulates proliferation, migration, differentiation, and
extracellular matrix turnover of human arterial smooth muscle cells.
Cardiovascular
Research 49, 851-862
(2001). |
| 73. |
Braun
N., Bachmann F., Horch B., Fischer-Frohlich C.L., Heyne N., Petersen
P., Viebahn R., Risler T.
Newly
developing proteinuria but not blood pressure is an independent risk
factor for chronic graft dysfunction following renal transplantation in
patients with well-controlled blood pressure.
Transplantation
Proceedings 33, 3361-3362 (2001).
|
| 72. |
Pereira
P.L., Schmidt D., Trubenbach J., Konig C.W., Viebahn R., Claussen C.D.
[Primary tumors of
the liver: radiologic interventional procedures].
Kongressband
der Deutschen Gesellschaft für Chirurgie, Kongr. 118,
194-199 (2001). |
| 71. |
Pereira
P.L., Truebenbach J., Koenig C.W., Viebahn R., Duda S.H., Claussen
C.D.
Phase
II study: Transarterial chemoembolization combined with single session
radiofrequency ablation of liver carcinomas larger than 5 cm.
Radiology
221,
250 (2001). |
| 70. |
Petersen
P., Lembert N., Wesche J., Enderle A., Zschocke P., Doser M., Heyne N.,
Viebahn R., Planck H., Ammon H.P.T., Becker H.D.
Improved
diffusion properties of a new polysulfone membrane for the development
of a bioartificial pancreas.
Transplantation
Proceedings 33, 1952-1953 (2001). |
| 69. |
Schenk
M., Zipfel A., Grenz A., Becker H.D., Viebahn R.
Cytokine
release from liver grafts during cold ischemia.
Transplantation
Proceedings 33, 3722-3723 (2001).
|
| 68. |
Schenk
M., Zipfel A., Kinder O., Lauchart W., Becker H.D., Viebahn R.
Soluble
adhesion molecules (sICAM-1 and sVCAM-1) in liver transplantation -
Beneficial or deleterious effects on graft function?
Gastroenterology
120,
A481 (2001). |
| 67. |
Schulz
C., Schenk M., Zipfel A., Becker H.D., Viebahn R.
New
aspects of RANTES in context of liver transplantation.
Transplantation
Proceedings 33, 414-415 (2001).
|
| 66. |
Siegel-Axel
D.I., Runge H., Viebahn R., Riessen R., Seipel L.
Effects
of cerivastatin on extracellular matrix constituents and matrix
metalloproteinase-2 under normal and hyperglycemic conditions.
Circulation 104, 259 (2001). |
| 65. |
Spyridopoulos I., Mayer P., Shook K.S., Axel D.I.,
Viebahn R., Karsch K.R.
Loss
of cyclin A and G1-cell cycle arrest are a prerequisite of
ceramide-induced toxicity in human arterial endothelial cells.
Cardiovascular
Research 50, 97-107
(2001). |
| 64. |
Zipfel
A., Schenk M., Grenz A., Lauchart W., Viebahn R.
TNF-alpha
and sCD14 as early markers of CMV susceptibility after liver
transplantation.
Transplantation
Proceedings 33, 1794-1795 (2001). |
| 63. |
Zipfel
A., Schenk M., Metzdorf B., Bode C., Viebahn R.
Release
of TNF-alpha from lipopolysaccharide (LPS)-stimulated Kupffer cells in
serum- and nutrient-free medium.
Inflammation
25,
287-292 (2001). |
| 62. |
Axel
D.I., Riessen R., Runge H., Viebahn R., Karsch K.R.
Effects
of cerivastatin on human arterial smooth muscle cell proliferation and
migration in transfilter cocultures.
Journal
of Cardiovascular Pharmacology 35, 619-629 (2000). |
| 61. |
Axel
D.I., Spyridopoulos I., Riessen R., Runge H., Viebahn R., Karsch K.R.
Toxicity,
uptake kinetics and efficacy of new transfection reagents: Increase of
oligonucleotide uptake.
Journal
of Vascular Research 37, 221-234 (2000). |
| 60. |
Grenz
A., Schenk M., Zipfel A., Viebahn R.
TNF-alpha
and its receptors mediate graft rejection and loss after liver
transplantation.
Clinical
Chemistry and Laboratory Medicine 38, 1183-1185 (2000). |
| 59. |
Muller
J., Schenk M., Zipfel A., Lauchart W., Viebahn R.
Influence
of perioperative sHLA I concentrations on the histological development
of the liver graft.
Transplant
International 13 (S1), S449-S451 (2000). |
| 58. |
Naegele
T., Grodd W., Viebahn R., Seeger U., Klose U., Seitz D., Kaiser S.,
Mader I., Mayer J., Lauchart W., Gregor M., Voigt K.
MR and H-1 spectroscopy of brain metabolites in hepatic
encephalopathy: Time-course of renormalization after liver
transplantation.
Radiology
216,
683-691 (2000). |
| 57. |
Schenk
M., Zipfel A., Grenz A., Hofer S., Weng H., Becker H.D., Viebahn R.
Cytokine
release from liver grafts during cold ischemia.
Gastroenterology 118, A1486 (2000). |
| 56. |
Schenk
M., Zipfel A., Kinder O., Lauchart W., Becker H.D., Viebahn R.
Soluble
adhesion molecules (sICAM-1 and sVCAM-1) in liver transplantation -
Beneficial or deleterious effects on graft function?
Gastroenterology
118,
A1486 (2000). |
| 55. |
Schenk
M., Zipfel A., Kratt T., Petersen P., Becker H.D., Viebahn R.
The
postoperative course of gamma-glutamyl transpeptidase - a marker of
cytomegalovirus (CMV) replication risk?
Clinical
Chemistry and Laboratory Medicine 38, 1181-1182 (2000). |
| 54. |
Schenk
M., Zipfel A., Sauer U., Lauchart W., Viebahn R.
The
quality of a liver graft.
Transplant
International 13 (S1), S288-S290
(2000). |
| 53. |
Schenk
M., Zipfel A., Schulz C., Becker H.D., Viebahn R.
RANTES
in the postoperative course after liver transplantation.
Transplant
International 13 (S1), S147-S149
(2000). |
| 52. |
Sessler
M.J., Baumstark C., Weik J., Weinlich M., Viebahn R., Becker H.D.
Intracellular
pH measurements in kidney in vitro - New advantages on single cell
diagnosis in the intact organ.
Gastroenterology
118,
A1109 (2000). |
| 51. |
Viebahn
R., Sessler M.J., Maiwald C., Kratt T.P., Petersen P., Becker H.D.
Is
there a benefit of portalvenous drainage in clinical pancreas
transplantation?
Gastroenterology
118,
A1535 (2000). |
| 50. |
Zipfel
A., Schenk M., Linti C., Dauner M., Planck H., Becker H.D., Viebahn R.
Cultivation
of pig hepatocytes in polyurethane non-wovens as the first step to an
artificial liver device.
Gastroenterology
118,
A1502 (2000). |
| 49. |
Zipfel
A., Schenk M., You MS., Lauchart W., Bode C., Viebahn R.
Endotoxemia
in organ donors: graft function following liver transplantation.
Transplant
International 13 (S1), S286-S287 (2000). |
| 48. |
Axel
D.I., Dittmann J., Runge H., Viebahn R., Karsch K.R.
All-trans
retinoic acid inhibits human arterial smooth muscle cell proliferation,
migration, differentiation, and matrix formation.
Circulation
100,
210 (1999). |
| 47. |
Baumstark
C., Weinlich M., Viebahn R., Sessler M.J., Becker H.D.
Hepatocellular
pH regulation and cell survival under experimental transplantation
conditions.
Gastroenterology 116, A1189 (1999). |
| 46. |
Duda
S.H., Konig C.W., Pinocy J., Schott U., Pereira P., Huppert P.E.,
Viebahn R., Claussen C.D.
Obstructive
jaundice - Palliative drainage from a radiologist's point of view.
Chirurgische
Gastroenterologie 15,
68-71 (1999). |
| 45. |
Siegel-Axel
D.I., Viebahn R., Betz E.L., Karsch K.R.
Progress
in the research of atherosclerosis and restenosis using an in vitro
method: Transfilter cocultures with human vascular cells.
Altex-Alternativen
zu Tierexperimenten 16,
117-122 (1999). |
| 44. |
Sinzger
C., Bissinger A.L., Viebahn R., Oettle H., Radke C., Schmidt C.A.,
Jahn G.
Hepatocytes
are permissive for human cytomegalovirus infection in human liver cell
culture and in vivo.
Journal
of Infectious Diseases 180, 976-986 (1999). |
| 43. |
Weinlich
M., Stirn R., Baumstark C., Viebahn R.
In
vitro simulation of kidney transplant preservation.
Gastroenterology
116,
A1288 (1999). |
| 42. |
Baumstark
C., Weinlich M., Viebahn R., Becker H.D.
Intracellar
pH- and Ca2+-changes under experimental transplantation conditions.
Gastroenterology 114, A1210 (1998). |
| 41. |
Kramer
B., Viebahn R., Petersen D., Klockgether T.
Leucoencephalopathy
induced by FK 506 (Tacrolimus).
Aktuelle
Neurologie 25, 76-79
(1998). |
| 40. |
Schenk
M., Zipfel A., Metzdorf B., Sauer U., Bode C., Lauchart W., Viebahn R.
Parameters
from liver graft perfusates - A valuable tool in the prediction of
outcome.
Hepatology 28, 738A (1998). |
| 39. |
Viebahn
R., Schenk M., Muller J., Lauchart W., Becker H.D.
Donor-HLA
A24 is beneficial in clinical liver transplantation.
Hepatology 28, 389A (1998). |
| 38. |
Viebahn
R., Thoma M., Kinder O., Schenk M., Lauchart W., Becker H.D.
Analysis
of intragraft adhesion molecules and their release in clinical liver
transplantation: Impact of reperfusion injury.
Transplantation
Proceedings 30, 4257-4259 (1998). |
| 37. |
Konig
C.W., Duda S.H., Pereira P., Viebahn R., Claussen C.D.
Kontrastverstärkte
MR-Cholangiographie bei perkutaner Gallenwegsdrainage. [Contrast-enhanced MR cholangiography
in percutaneous
bile duct drainage].
RöFo: Fortschritte
auf dem Gebiete der Röntgenstrahlen, der Nuklearmedizin 167,
384-386 (1997).
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-2007-1015548
|
| 36. |
Lauchart
W., Koveker G., Viebahn R., Schott U., Judt-Stelzer G.
No
impairment of hepatic venous outflow after ''piggy-back'' liver
transplantation.
Transplantation
Proceedings 29, 2864-2865 (1997). |
| 35. |
Sessler
M.J., Starlinger M., Viebahn R., Boxberger H.J., Jehle E., Meyer T.F., Becker H.D.
Primary
epithelial cells from normal colon grown as multicellular vesicles -
New advances in experimental models.
Gastroenterology 112, A403 (1997). |
| 34. |
Viebahn
R., Pufke I., Koveker G., Lauchart W., Becker H.D.
CMV
infection after liver transplantation: Remaining risk factors under
prophylactic/preemptive therapy.
Gastroenterology
112,
A1409 (1997). |
| 33. |
Viebahn
R., Schweizer A., Schenk M., Sessler M.J., Bode C., Lauchart W.,
Becker H.D.
MHC
expression in liver ischemia: Induction by mediators is an alternative
pathway to hypoxic upregulation.
Gastroenterology
112,
A1409 (1997). |
| 32. |
Gohl
G., Lehmkoster T., Munzel P. A., Schrenk D., Viebahn R., Bock K.W.
TCDD-inducible
plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes,
HepG2 and monocytic U937 cells.
Carcinogenesis
17,
443-449 (1996). |
| 31. |
Koveker
G., Viebahn R., Schott U., Becker H.D., Lauchart W.
Comparison
of venous drainage following ''piggy back'' and ''standard'' liver
transplantation.
Gastroenterology
110,
A1399 (1996). |
| 30. |
Koveker
G., Viebahn R., Schott U., Judt-Stelzer G., Becker H.D., Lauchart W.
[Does
piggy-back liver transplantation have a detrimental effect on venous
drainage?--A comparative duplex ultrasound study].
Langenbecks
Archiv für Chirurgie, Suppl Kongressbd. 113,
402-404 (1996). |
| 29. |
Viebahn
R., Polap R., Thoma M., Grenz A., Hofer S., Kovecker G., Lauchart W.,
Becker H.D.
Intragraft
immune activation-prospective study in 50 human liver transplantations.
Gastroenterology 110, A1354 (1996). |
| 28. |
Viebahn
R., Sauer U., Schenk M., Kovecker G., Lauchart W., Becker H.D.
Severe
reperfusion injury after liver transplantation predictive value of
biochemical parameters from graft perfusates.
Gastroenterology
110,
A1354 (1996). |
| 27. |
Schrenk
D., Stuven T., Gohl G., Viebahn R., Bock K.W.
Induction
of Cyp1A and Glutathione-S-Transferase Activities by
2,3,7,8-Tetrachlorodibenzo-P-Dioxin in Human Hepatocyte Cultures.
Carcinogenesis
16,
943-946 (1995). |
| 26. |
Viebahn R.,
Harsch C., Metzdorf B., Eisenberger C., Lauchart W., Becker H.D.
Pentoxyfylline
and Epoprosterenol Regulate Mhc Expression on Epithelial and
Endothelial Liver-Cells Under Hypoxic Stress.
Gastroenterology
108,
A1194 (1995). |
| 25. |
Viebahn R.,
Muller K., Kovecker G., Lauchart W., Becker H.D.
Severe
Reperfusion Injury After Liver-Transplantation - Outcome in 5 Patients
Managed Without Retransplantation.
Gastroenterology
108,
A1195 (1995). |
| 24. |
Weinlich M.,
Baumstark C., Viebahn R., Starlinger M.
Conservation
of Intracellular Ph After Cold Ischemia in Rat Hepatocytes - Effect of
Different Preservation Solutions.
Gastroenterology
108,
A1197 (1995). |
| 23. |
Eisenberger
C. F., Viebahn R., Lauchart W., de Groot H., Becker H.D.
MHC
antigen presentation on the surface of hepatocytes: modulation during
and after hypoxic stress.
Transplant
International 7 (S1), S163-S166 (1994). |
| 22. |
Huppert P.E., Viebahn R., Duda S.H., Lauchart W.
Interventional
Radiology in the Treatment of Hepatocellular-Carcinoma.
Zentralblatt
für Chirurgie 119,
787-793 (1994). |
| 21. |
Lauchart W.,
Sessler M.J., Viebahn R., Naruhn M., Huppert P.E., Becker H.D.
Hepatic Resection
for Hepatocellular-Carcinoma.
Zentralblatt
für Chirurgie 119,
764-771 (1994). |
| 20. |
Lauchart W.,
Viebahn R., De Groot H.
Acute
Liver-Failure.
Zentralblatt
für Chirurgie 119,
285-286 (1994). |
| 19. |
Rauen U.,
Viebahn R., Lauchart W., de Groot H.
The
Potential Role of Reactive Oxygen Species in Liver Ischemia/Reperfusion
Injury Following Liver Surgery.
Hepato-Gastroenterology
41,
333-336 (1994). |
| 18. |
Viebahn R.,
Eisenberger C., Lauchart W., Becker H.D.
MHC
Expression on Epithelial and Endothelial Liver-Cells - Modulation
During and After Hypoxic Stress.
Gastroenterology 106, A1004 (1994). |
| 17. |
Viebahn R.,
Metzdorf B., Besenthal I.
Preservation
studies using acinar cell cultures of the pancreas: stimulation of
amylase/lipase release before and after hypoxic stress.
Transplant
International 7 (S1), S446-S448 (1994). |
| 16. |
Weber P.,
Scheurlen M., Irkin I., Viebahn R., Schareck W., Becker W., de Groot
H., Lauchart W.
[Liver
transplantation in halothane-induced liver necrosis].
Zentralblatt
für Chirurgie 119,
305-308 (1994). |
| 15. |
Viebahn R.,
Maurer F., Weise K.
[Acute
cholecystitis in a traumatologic patient sample].
Aktuelle
Traumatologie 23,
32-35 (1993). |
| 14. |
Viebahn R.,
Metzdorf B., De Groot H., Lauchart W.
Simulation
of Hypoxic and Preservation Injury in Human Hepatocyte Cultures -
Influence of Fk-506 and Cyclosporine.
Transplantation
Proceedings 25, 2691-2692 (1993).
|
| 13. |
Hugo-Wissemann
D., Anundi I., Lauchart W., Viebahn R., de Groot H.
Differences
in glycolytic capacity and hypoxia tolerance between hepatoma cells and
hepatocytes.
Hepatology
13,
297-303 (1991). |
| 12. |
Viebahn R.,
De Groot H., Lauchart W., Becker H.D.
Hypoxic
and Reoxygenation Injury in Human and Rat Hepatocytes - Influence of
Fk-506 and Cyclosporine.
Transplantation
Proceedings 23, 3183-3184 (1991). |
| 11. |
Viebahn R.,
de Groot H., Lauchart W., Becker H.D.
[Primary hepatocyte cultures as a model of experimental
study of liver preservation].
Langenbecks Archiv
für Chirurgie 376,
268-272 (1991). |
| 10. |
Viebahn R.
Moderne
Strategien bei primären und sekundären Lebertumoren.
Deutsches
Ärzteblatt 87 (12),
A-942 (1990).
Link
zum Artikel.
|
| 9. |
Hanf V.,
Viebahn R., Lauchart W., Tinneberg H.R.
Pregnancy
and Delivery After Liver-Transplantation.
Geburtshilfe
und Frauenheilkunde 50,
813-815 (1990). |
| 8. |
Viebahn R.,
De Groot H., Lauchart W., Becker H. D.
Primary
Hepatocyte Culture - A Model for the Study of Liver Preservation.
Transplantation
Proceedings 22, 511-512 (1990).
|
| 7. |
Büsing M.,
Greger B., Mellert J., Holzer H., Viebahn R., Lauchart W., Hopt U.T.
Acute
Respiratory Insufficency Due to Okt3 Therapy in Organ-Transplantation.
Atemwegs-und
Lungenkrankheiten 15,
330-332 (1989). |
| 6. |
Lauchart
W., Viebahn R.
[Liver
transplantation: morphologic and functional adaptation of the
transplant].
Zeitschrift für
Gastroenterologie. Verhandlungsband
24, 239-240 (1989). |
| 5. |
Viebahn R.,
Lauchart W., Becker H.D.
Surgical-Treatment
of Cancer of the Liver and of the Bile-Ducts.
Ultraschall in
der Medizin 10,
119-122 (1989). |
| 4. |
Frei U.,
Margreiter R., Harms A., Bosmuller C., Neumann K.H., Viebahn R.,
Gubernatis G., Wonigeit K., Pichlmayr R.
Preoperative
Graft Reperfusion with A Calcium-Antagonist Improves Initial Function -
Preliminary-Results of A Prospective Randomized Trial in 110 Kidney
Recipients.
Transplantation
Proceedings 19, 3539-3541 (1987). |
| 3. |
Gubernatis
G., Witteck C.H., Viebahn R.
Unusual
Course of Extrapulmonary Tuberculosis with Hepatic Involvement -
Case-Report.
Zeitschrift für
Gastroenterologie 25,
34-35 (1987). |
| 2. |
Viebahn R.,
Strauch S., Heidl G.
Hepatocarcinoma and
Intrauterine Acquired Chronic Persisting Hepatitis - Case-Report.
Zeitschrift für
Gastroenterologie 25,
34 (1987). |
| 1. |
Viebahn R.,
Hiddemann W., Klinke F., Vonbassewitz D.B.
Thymus
Carcinoid.
Pathology
Research and Practice 180, 445-448 (1985). |
|
| Direktor: |
Prof.
Dr. Richard Viebahn
|
| Anschrift: |
Chirurgische Universitätsklinik
 Universitätsklinikum
Knappschaftskrankenhaus Bochum GmbH
In der Schornau 23-25
44892 Bochum |
|
